CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2022 GI Fellow Board of Advisors
Embassy of Education  
Slide Library Webcasts Annotations Abstract Library Committee Members
 
HBV | Abstract Library
Abstract Library
 
The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.
1.Integrated hepatitis B virus DNA maintains surface antigen production during antivirals
 

J Clin Invest. 2022 Jul 7;e161818. doi: 10.1172/JCI161818. Online ahead of print.

Tanner Grudda 1, Hyon S Hwang 2, Maraake Taddese 2, Jeffrey Quinn 2, Mark S Sulkowski 2, Richard K Sterling 3, Ashwin Balagopal 2, Chloe L Thio 1
 
2.Predicting hepatitis B e Antigen seroconversion after pregnancy-The SydPregScore
 

Liver Int. 2022 Jul 21. doi: 10.1111/liv.15372. Online ahead of print.

Cynthuja Thilakanathan 1 2, Tahrima Kayes 1, Julia Di Girolamo 1, Vi Nguyen 2, Anne Glass 1, Sicha Manandhar 1, Joseph Lawler 3, Chris Meredith 3, Michael Maley 2 4, Andrew Lloyd 5, Miriam T Levy 1 2
 
3.Health care costs related to hepatitis B in Finland are mostly due to chronic infections: a register-based study
 

Infect Dis (Lond). 2022 Jul 20;1-9. doi: 10.1080/23744235.2022.2082519. Online ahead of print.

Tanja Nieminen 1, Heini Salo 1, Markku Nurhonen 2, Tuija Leino 1
 
4.Hepatitis B Vaccination of Low Birth Weight Infants in Washington State
 

Am J Perinatol. 2022 Jul;39(9):980-986. doi: 10.1055/s-0040-1721372. Epub 2020 Nov 30.

Katarina Ost 1, Natalia V Oster 2, Elizabeth N Jacobson 3, M Patricia deHart 4, Janet A Englund 1 3, Annika M Hofstetter 1 3
 
5.Hepatitis B Virus Reactivation Associated with New Classes of Immunosuppressants and Immunomodulators: A Systematic Review, Meta-analysis, and Expert Opinion
 

J Hepatol. 2022 Jul 15;S0168-8278(22)02935-X. doi: 10.1016/j.jhep.2022.07.003.Online ahead of print.

George V Papatheodoridis 1, Vasileios Lekakis 1, Thodoris Voulgaris 2, Pietro Lampertico 3, Thomas Berg 4, Henry L Y Chan 5, Jia-Horng Kao 6, Norah Terrault 7, Anna S Lok 8, K Rajender Reddy 9
 
6.Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease
 

Pediatr Qual Saf. 2022 Jun 23;7(4):e570. doi: 10.1097/pq9.0000000000000570.eCollection 2022 Jul-Aug.

Megan Megan McNicol 1, Amy Donegan 2, Kate Hawa 3, Angelique E Boutzoukas 3, Barb Drobnic 2, Melanie Oates 2, Maudie Orraca-Tetteh 2, Hilary K Michel 2, Ross M Maltz 2, Jennifer L Dotson 2, Don Buckingham 4, Brendan Boyle 2, Monica I Ardura 5
 
7.Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection
 

J Hepatol. 2022 Jun 10;S0168-8278(22)00348-8. doi: 10.1016/j.jhep.2022.05.027.Online ahead of print.

Mark S Sulkowski 1, Kosh Agarwal 2, Xiaoli Ma 3, Tuan T Nguyen 4, Eugene R Schiff 5, Hie-Won L Hann 6, Douglas T Dieterich 7, Ronald G Nahass 8, James S Park 9, Sing Chan 10, Steven-Huy B Han 11, Edward J Gane 12, Michael Bennett 13, Katia Alves 14, Marc Evanchik 14, Ran Yan 14, Qi Huang 14, Uri Lopatin 14, Richard Colonno 14, Julie Ma 14, Steven J Knox 14, Luisa M Stamm 14, Maurizio Bonacini 15, Ira M Jacobson 9, Walid S Ayoub 16, Frank Weilert 17, Natarajan Ravendhran 18, Alnoor Ramji 19, Paul Yien Kwo 20, Magdy Elkhashab 21, Tarek Hassanein 22, Ho S Bae 23, Jacob P Lalezari 15, Scott K Fung 24, Man-Fung Yuen 25
 
8.Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination
 

Clin Infect Dis. 2022 May 20;ciac385. doi: 10.1093/cid/ciac385. Online ahead of print.

Robert J Wong 1 2, Harvey W Kaufman 3, Justin K Niles 3, Hema Kapoor 3, Robert G Gish 4
 
9.Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection
 

Aliment Pharmacol Ther. 2022 Aug;56(3):510-518. doi: 10.1111/apt.17040. Epub 2022 May 22.

Tahrima Kayes 1 2, Harry Crane 1 2, Allison Symonds 3, Julie Dumond 3, Mackenzie Cottrell 3, Julia Di Girolamo 1 2, Sicha Manandhar 1 2, Tien Huey Lim 4, Edward Gane 5, Angela Kashuba 3, Miriam T Levy 1 2 6
 
10.Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022
 

MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):844-846. doi: 10.15585/mmwr.mm7126a2.

Rebecca J Free, Marilyn E Levi, James S Bowman, Danae Bixler, John T Brooks, Kate Buchacz, Anne Moorman, James Berger, Sridhar V Basavaraju
 
11.Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years
 

Liver Int. 2022 Jun 26. doi: 10.1111/liv.15347. Online ahead of print.

Nicolette Veracruz 1, Robert G Gish 2, Ramsey Cheung 3 4, Amit S Chitnis 5, Robert J Wong 3 4
 
12.Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis
 

J Gastroenterol Hepatol. 2022 May;37(5):782-794. doi: 10.1111/jgh.15783.Epub 2022 Feb 7.

Bao-Hong Yuan 1, Ru-Hong Li 1, Rong-Rui Huo 2, Min-Jun Li 2, George Papatheodoridis 3, Jian-Hong Zhong 2
 
13.Heplisav-B in Prior Hepatitis B Vaccine Nonresponders: A Case Series
 

Mil Med. 2022 Jul 1;187(7-8):e811-e813. doi: 10.1093/milmed/usab397.

Alan L Williams 1
 
14.Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients
 

Infect Dis. 2022 Jun 1;225(11):1974-1981. doi: 10.1093/infdis/jiab596.

Chien-Hung Chen 1, Cheng-Yuan Peng 2 3, Yuan-Hung Kuo 1, Tsung-Hui Hu 1, Chao-Hung Hung 1, Jing-Houng Wang 1, Sheng-Nan Lu 1
 
15.Hepatitis B Core Antibody Positivity Associated with Increased Risk of Liver Cancer in Patients with Chronic Hepatitis C: Analysis of a Large Patient Cohort in Hawai'i
 

Hawaii J Health Soc Welf. 2022 May;81(5):127-133.

Olivia A Collis 1, Patrycja A Ashley 2, Li-Hsieh Chen 2, Kathryn L Pedula 3, Shelley M Miyashiro 4, Shellie K Yamashita 4
 
16.Regional Differences in Mortality Rates and Characteristics of Decedents With Hepatitis B Listed as a Cause of Death, United States, 2000-2019
 

JAMA Netw Open. 2022 Jun 1;5(6):e2219170. doi: 10.1001/jamanetworkopen.2022.19170.

Kathleen N Ly 1, Shaoman Yin 1, Philip R Spradling 1
 
17.Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis
 

Dig Dis Sci. 2022 Jun;67(6):2646-2654. doi: 10.1007/s10620-021-07056-5.Epub 2021 May 30.

Jennie Chen 1 2, Ashley Hubbard 3, Laurie Bagley 3 4, Rita Shiau 5, Robert J Wong # 6 7, Amit S Chitnis # 1
 
18.A Rapid Review of Interventions to Increase Hepatitis B Testing, Treatment, and Monitoring among Migrants Living in Australia
 

Int J Environ Res Public Health. 2022 May 13;19(10):5947.doi: 10.3390/ijerph19105947.

Vishnupriya Rajkumar 1, Kahlia McCausland 1 2, Roanna Lobo 1 2
 
19.Viral hepatitis in pregnancy
 

J Viral Hepat. 2022 Jun 24. doi: 10.1111/jvh.13725. Online ahead of print.

Mohamed Tarek M Shata 1, Helal F Hetta 1 2, Yeshika Sharma 1, Kenneth E Sherman 1
 
20.Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?
 

Liver Int. 2022 Jun 29. doi: 10.1111/liv.15352. Online ahead of print.

Ferenci Peter 1, Reiberger Thomas 1, Stadlbauer Vanessa 2, Zoller Heinz 3
 
21.Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
 

World J Gastroenterol. 2022 Jun 7;28(21):2251-2281. doi: 10.3748/wjg.v28.i21.2251.

Leonardo Stella 1, Francesco Santopaolo 1, Antonio Gasbarrini 1, Maurizio Pompili 1, Francesca Romana Ponziani 2
 
22.A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV 'cure'
 

J Hepatol. 2022 Jul;77(1):245-248. doi: 10.1016/j.jhep.2022.03.006.Epub 2022 Mar 28.

Kosh Agarwal 1, James Lok 2, Ivana Carey 2, Yatin Shivkar 3, Michael Biermer 3, Thomas Berg 4, Isabelle Lonjon-Domanec 3
 
23.Novel therapeutic strategies for Chronic Hepatitis B
 

Virulence. 2022 Jun 28. doi: 10.1080/21505594.2022.2093444.Online ahead of print.

Sandra Phillips 1, Ravi Jagatia 1, Shilpa Chokshi 1
 
24.Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis
 

JAMA Netw Open. 2022 Jun 1;5(6):e2219407.doi: 10.1001/jamanetworkopen.2022.19407.

Darren Jun Hao Tan 1, Cheng Han Ng 1, Phoebe Wen Lin Tay 1, Nicholas Syn 1, Mark D Muthiah 1 2 3, Wen Hui Lim 1, Ansel Shao Pin Tang 1, Kai En Lim 1, Grace En Hui Lim 4, Nobuharu Tamaki 5, Beom Kyung Kim 5 6 7, Margaret Li Peng Teng 1 2 3, James Fung 8, Rohit Loomba 9, Mindie H Nguyen 10, Daniel Q Huang 1 2 3 9
 
25.The dilemma of cytomegalovirus and hepatitis B virus interaction
 

Gastroenterol Rep (Oxf). 2022 May 26;10:goac018. doi: 10.1093/gastro/goac018.eCollection 2022.

Muzammil M Khan 1, Mukarram J Ali 1, Hira Hanif 1, Muhammad H Maqsood 1, Imama Ahmad 2, Javier E G Alvarez 1, Maria-Andreea Catana 1, Daryl T Y Lau 1
 
26.Review article: Novel biomarkers in hepatitis B infection
 

Aliment Pharmacol Ther. 2022 Jun 30. doi: 10.1111/apt.17105. Online ahead of print.

James Lok 1, Geoffrey Dusheiko 1, Ivana Carey 1, Kosh Agarwal 1
 
27.Immunological insights in the treatment of chronic hepatitis B
 

Curr Opin Immunol. 2022 May 16;77:102207. doi: 10.1016/j.coi.2022.102207.Online ahead of print.

Matteo Iannacone 1, Francesco Andreata 2, Luca G Guidotti 3
 
28.Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels
 

Aliment Pharmacol Ther. 2022 May 6. doi: 10.1111/apt.16968. Online ahead of print.

Samuel A L Hall 1 2, Gareth S Burns 1 2, Despina Anagnostou 1, Sara Vogrin 2, Vijaya Sundararajan 2 3, Dilip Ratnam 4 5, Miriam T Levy 6, John S Lubel 7 8, Amanda J Nicoll 9, Simone I Strasser 10 11, William Sievert 4 5, Paul V Desmond 1, Meng C Ngu 12, Peter Angus 13 14, Marie Sinclair 13, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 17, Kathy Jackson 17, Margaret Littlejohn 17, D Scott Bowden 17, Stephen A Locarnini 17, Kumar Visvanathan 1 2, Alexander J Thompson 1 2
 
29.How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
 

J Hepatol. 2022 Jun;76(6):1249-1262. doi: 10.1016/j.jhep.2021.11.024.

Grace L H Wong 1, Ed Gane 2, Anna S F Lok 3
 
30.Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review
 

Lancet Gastroenterol Hepatol. 2022 May 13;S2468-1253(22)00050-4.doi: 10.1016/S2468-1253(22)00050-4. Online ahead of print.

Catharina J Alberts 1, Gary M Clifford 2, Damien Georges 2, Francesco Negro 3, Olufunmilayo A Lesi 4, Yvan J-F Hutin 5, Catherine de Martel 2
 
31.Acute hepatitis B in pregnancy with surprisingly rapid clearance of serum HBs antigen associated with a favourable outcome
 

Int J Infect Dis. 2022 May;118:141-143. doi: 10.1016/j.ijid.2022.02.053.Epub 2022 Feb 27.

Steven Roger 1, Julien Fontana 2, Alexandra Ducancelle 3, Hélène Le Guillou-Guillemette 3, Clémence M Canivet 4, Caroline Lefeuvre 5
 
32.Australian consensus recommendations for the management of hepatitis B
 

Med J Aust. 2022 May 16;216(9):478-486. doi: 10.5694/mja2.51430. Epub 2022 Mar 6.

John S Lubel 1 2, Simone I Strasser 3 4, Alexander J Thompson 5 6, Benjamin C Cowie 7 8, Jennifer MacLachlan 7, Nicole L Allard 6 7, Jacinta Holmes 5 6, William W Kemp 1, Avik Majumdar 3, David Iser 5, Jess Howell 2 6 9, Gail V Matthews 10 11
 
33.The unvirtuous cycle of discrimination affecting people with hepatitis B: a multi-country qualitative assessment of key-informant perspectives
 

Int J Equity Health. 2022 May 31;21(1):77.doi: 10.1186/s12939-022-01677-6.

Catherine Freeland 1, Lindsay Mendola 2, Vivian Cheng 3, Chari Cohen 4, Jack Wallace 5 6 7
 
34.Gaps in Hepatitis A and Hepatitis B Vaccination Among Hepatitis C Antibody-Positive Individuals Experiencing Homelessness
 

Open Forum Infect Dis. 2022 Apr 7;9(5):ofac175. doi: 10.1093/ofid/ofac175.eCollection 2022 May.

Diana Partida 1, Jesse Powell 2, Daniel Gonzalez 1, Mandana Khalili 1
 
35.Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection
 

Clin Drug Investig. 2022 May 28. doi: 10.1007/s40261-022-01163-5. Online ahead of print.

Matteo Megna 1, Cataldo Patruno 2, Maria Rita Bongiorno 3, Alessio Gambardella 4, Claudio Guarneri 5, Paolo Romita 6, Annunziata Raimondo 7, Francesco Loconsole 6, Gabriella Fabbrocini 8
 
36.Adult immunization against hepatitis B: Does the number of jabs matter?
 

Vaccine. 2022 Jun 9;40(26):3597-3604. doi: 10.1016/j.vaccine.2022.04.080. Epub 2022 May 12.

Gerry Oster 1, Rebecca Bornheimer 2, Kevin Ottino 2, Catherine Stevenson 3, Clem Lewin 4, Robert Janssen 3
 
37.Hepatitis B Virus-Associated Hepatocellular Carcinoma
 

Viruses. 2022 May 7;14(5):986. doi: 10.3390/v14050986.

Giacomo Emanuele Maria Rizzo 1 2 3, Giuseppe Cabibbo 1, Antonio Craxì 1
 
38.The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
 

Vaccines (Basel). 2022 May 17;10(5):793. doi: 10.3390/vaccines10050793.

Joan Ericka Flores 1 2, Alexander J Thompson 1 2 3, Marno Ryan 1 2 3, Jessica Howell 1 2 3 4
 
39.HBV-positive and HIV-positive organs in transplantation: a clinical guide for the hepatologist
 

J Hepatol. 2022 Apr 7;S0168-8278(22)00175-1. doi: 10.1016/j.jhep.2022.03.007.Online ahead of print.

Francesco Paolo Russo 1, Mauro Viganò 2, Peter Stock 3, Alberto Ferrarese 4, Nicola Pugliese 5, Patrizia Burra 6, Alessio Aghemo 5
 
40.HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
 

Viruses. 2022 Mar 22;14(4):657. doi: 10.3390/v14040657.

Maryam Moini 1, Scott Fung 2
 
41.Care of the Hepatology Patient in the COVID-19 Era
 

Curr Hepatol Rep. 2022 Apr 1;1-12. doi: 10.1007/s11901-021-00581-x.Online ahead of print.

Kathryn E Driggers 1, Brett W Sadowski 2, Eva Shagla 3, Ryan M Kwok 4
 
42.Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
 

Pathogens. 2022 May 11;11(5):567. doi: 10.3390/pathogens11050567.

Caterina Sagnelli 1, Antonello Sica 2, Massimiliano Creta 3, Alessandra Borsetti 4, Massimo Ciccozzi 5, Evangelista Sagnelli 1
 
43.Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes
 

Liver Int. 2022 Mar 21.doi: 10.1111/liv.15249. Online ahead of print.

Golasa Samadi Kochaksaraei 1, Abdel A Shaheen 1 2, Cynthia H Seow 1 2, Herman W Barkema 2 3, Carla S Coffin 1
 
44.Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data
 

Aliment Pharmacol Ther. 2022 Apr;55(8):921-943. doi: 10.1111/apt.16788.Epub 2022 Feb 17.

Young-Suk Lim 1, Wai-Kay Seto 2 3, Masayuki Kurosaki 4, Scott Fung 5, Jia-Horng Kao 6, Jinlin Hou 7, Stuart C Gordon 8, John F Flaherty 9, Leland J Yee 9, Yang Zhao 9, Kosh Agarwal 10, Pietro Lampertico 11 12
 
45.Risk of HBV reactivation during therapies for HCC: A systematic review
 

Hepatology. 2022 May;75(5):1257-1274. doi: 10.1002/hep.32241. Epub 2021 Dec 16.

Margarita Papatheodoridi 1, Maria Tampaki 2, Anna S Lok 3, George V Papatheodoridis 2
 
46.Hepatitis B Virus Genotype G: The Odd Cousin of the Family
 

Front Microbiol. 2022 Mar 31;13:872766. doi: 10.3389/fmicb.2022.872766.eCollection 2022.

Natalia M Araujo 1, Carla Osiowy 2
 
47.Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection
 

JHEP Rep. 2022 Apr 2;4(6):100480. doi: 10.1016/j.jhepr.2022.100480.eCollection 2022 Jun.

Tobias Boettler 1, Upkar S Gill 2, Lena Allweiss 3 4, Teresa Pollicino 5, John E Tavis 6, Fabien Zoulim 7
 
48.Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease
 

Am J Gastroenterol. 2022 Feb 1;117(2):253-263.doi: 10.14309/ajg.0000000000001575.

Patrice Cacoub 1 2 3 4, Tarik Asselah 5 6
 
49.Clearance of hepatitis B "e" antigen in untreated chronic HBV infection: a systematic review and meta-analysis
 

J Infect Dis. 2022 May 2;jiac168. doi: 10.1093/infdis/jiac168. Online ahead of print.

Amir M Mohareb 1 2 3, Anne F Liu 3 4, Arthur Y Kim 2 3, Patrick A Coffie 5 6, Menan Gérard Kouamé 6, Kenneth A Freedberg 1 2 3 7, Anders Boyd 8 9, Emily P Hyle 1 2 3
 
50.Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort
 

Liver Transpl. 2022 Jan;28(1):39-50. doi: 10.1002/lt.26187. Epub 2021 Jul 20.

Natalie Z Wong 1, K Rajender Reddy 2, Therese Bittermann 2 3
 
51.Adefovir for lamivudine-resistant hepatitis B
 

Antivir Ther. 2022 Apr;27(2):13596535211067605.doi: 10.1177/13596535211067605.

Rebecca Roediger 1, Elizabeth Kula Smyth 2, Douglas Dieterich 1
 
52.Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature
 

Rev Med Virol. 2022 Apr 20;e2353. doi: 10.1002/rmv.2353. Online ahead of print.

Ahmed M Afifi 1, Anas Elgenidy 2, Mahmoud Hashim 3, Ahmed K Awad 4, Prasun K Jalal 5
 
53.Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy
 

Hepatol Int. 2022 Apr;16(2):211-253. doi: 10.1007/s12072-021-10285-5.Epub 2022 Feb 3.

Manoj Kumar 1, Zaigham Abbas 2, Milad Azami 3, Maria Belopolskaya 4, A K Dokmeci 5, Hasmik Ghazinyan 6, Jidong Jia 7, Ankur Jindal 8, Han Chu Lee 9, Wei Lei 10, Seng Gee Lim 11, Chun-Jen Liu 12, Qiang Li 13, Mamun Al Mahtab 14, David H Muljono 15, Madunil Anuk Niriella 16, Masao Omata 17 18, Diana A Payawal 19, Shiv K Sarin 20, Olivier Ségéral 21, Tawesak Tanwandee 22, Nirupma Trehanpati 23, Kumar Visvanathan 24, Jin Mo Yang 25, Man-Fung Yuen 26, Yingjie Zheng 27, Y H Zhou 28
 
54.Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine
 

Hum Vaccin Immunother. 2021 Nov 2;17(11):4567-4577. doi: 10.1080/21645515.2021.1965807.Epub 2021 Sep 10.

Catherine Stevenson 1, Ji-Hee Youn 2, Mary S Hayney 3, Coline David 1
 
55.Hepatitis B and Health Care Workers
 

Clin Liver Dis. 2021 Nov;25(4):859-874. doi: 10.1016/j.cld.2021.06.010.Epub 2021 Sep 11.

Stephen C Pappas 1
 
56.The viral hepatitis B care cascade: A population-based comparison of immigrant groups
 

Hepatology. 2022 Mar;75(3):673-689. doi: 10.1002/hep.32162. Epub 2021 Dec 7.

Abdool S Yasseen 1 2 3, Jeffrey C Kwong 1 2 3 4 5, Jordan J Feld 1 2 4 6, Rafal Kustra 1, Liane MacDonald 1 3, Christina C Greenaway 7 8 9, Naveed Z Janjua 10, Tony Mazzulli 3 4, Morris Sherman 4, Lauren Lapointe-Shaw 2 4 6, Beate Sander 1 2 3 4, Natasha S Crowcroft 1 2 3
 
57.Cure everyone and vaccinate the rest: The patient perspective on future hepatitis B treatment
 

J Viral Hepat. 2021 Nov;28(11):1539-1544. doi: 10.1111/jvh.13592. Epub 2021 Aug 11.

Catherine Freeland 1, Rhea Racho 1, Maureen Kamischke 1, Kate Moraras 1, Evangeline Wang 1, Chari Cohen 1
 
58.Hepatitis B-Associated Lupus-Like Glomerulonephritis Successfully Treated With Antiretroviral Drugs and Prednisone: A Case Report and Literature Review
 

J Investig Med High Impact Case Rep. Jan-Dec 2022;10:23247096221086451.doi: 10.1177/23247096221086451.

Sasmit Roy 1, Rohan Gupta 2, Sreedhar Adapa 3, Subhashish Bose 1, Amarinder Garcha 3
 
59.Drugs of Abuse and Their Impact on Viral Pathogenesis
 

Viruses. 2021 Nov 29;13(12):2387. doi: 10.3390/v13122387.

Jason T Blackard 1 2, Kenneth E Sherman 1 2
 
60.Role of Hepatitis B Surface Antibodies in Risk for Hepatitis B Virus Reactivation During Anti-Tumor Necrosis Factor Therapy
 

Clin Gastroenterol Hepatol. 2022 Feb 18;S1542-3565(22)00183-5.doi: 10.1016/j.cgh.2022.02.027. Online ahead of print.

Shiva Poola 1, Marykate Kratzer 2, Sirish Sanaka 3, Kerry Sewell 4, Hans L Tillmann 5
 
61.Prevalence of hepatitis B surface antigen and hepatitis B core antibody among adults with latent tuberculosis infection
 

Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e610-e614.doi: 10.1097/MEG.0000000000002180.

Ashley Hubbard 1, Grishma Hirode 2, Amit Chitnis 3, Robert Wong 4 5
 
62.Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection
 

J Antimicrob Chemother. 2022 Mar 31;77(4):1102-1110.doi: 10.1093/jac/dkab491.

Ed J Gane 1, Christian Schwabe 2, Elina Berliba 3 4, Pisit Tangkijvanich 5, Alina Jucov 3 4, Nelea Ghicavii 3, Thierry Verbinnen 6, Oliver Lenz 6, Willem Talloen 6, Thomas N Kakuda 7, Chris Westland 7, Megha Patel 7, Jeysen Z Yogaratnam 7, Leonard Dragone 7, Pieter Van Remoortere 8
 
63.Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019
 

J Viral Hepat. 2022 May;29(5):352-365. doi: 10.1111/jvh.13663. Epub 2022 Mar 15.

Nicolette Veracruz 1, Robert G Gish 2, Ramsey Cheung 3 4, Amit S Chitnis 5, Robert J Wong 3 4
 
64.The impact of hepatitis B vaccination in the United States, 1999-2018
 

Hepatology. 2021 Dec 2. doi: 10.1002/hep.32265. Online ahead of print.

Wen-Qiang He 1, Guan Nan Guo 1 2, Chenxi Li 1
 
65.Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study
 

J Viral Hepat. 2021 Dec;28(12):1690-1698. doi: 10.1111/jvh.13608.Epub 2021 Sep 29.

Robin Erken 1, Patrice Andre 2, Elise Roy 3, Neeltje Kootstra 4, Noelie Barzic 3, Hugo Girma 3, Christian Laveille 5, Pauline Radreau-Pierini 3, Raphael Darteil 3, Jacky Vonderscher 3, Pietro Scalfaro 3, Pisit Tangkijvanich 6, Robert Flisiak 7, Henk Reesink 8
 
66.Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment
 

J Patient Rep Outcomes. 2021 Nov 10;5(1):121. doi: 10.1186/s41687-021-00398-8.

Catherine Freeland 1, Rhea Racho 2, Maureen Kamischke 2, Kate Moraras 2, Evangeline Wang 2, Chari Cohen 2, Stuart Kendrick 3
 
67.Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner
 

Vaccine. 2022 Feb 23;40(9):1334-1341.doi: 10.1016/j.vaccine.2022.01.005. Epub 2022 Jan 31.

Laure F Pittet 1, Lianne Cox 2, Bridget Freyne 3, Susie Germano 4, Rhian Bonnici 5, Kaya Gardiner 6, Susan Donath 7, Clare L Collins 8, Dan Casalaz 9, Roy Robins-Browne 10, Katie L Flanagan 11, Nicole L Messina 12, Nigel Curtis 13
 
68.Circulating hepatitis B virus RNA: From biology to clinical applications
 

Hepatology. 2022 Mar 28. doi: 10.1002/hep.32479. Online ahead of print.

Rui Deng 1, Shi Liu 1, Sheng Shen 1 2, Haitao Guo 2, Jian Sun 1
 
69.An Evidence-based Practical Guide to Vaccination for Hepatitis B Virus
 

J Clin Gastroenterol. 2022 Apr 7. doi: 10.1097/MCG.0000000000001695. Online ahead of print.

Ira M Jacobson 1, Robert S Brown Jr 2, Brian J McMahon 3 4 5, Robert P Perrillo 6, Robert Gish 7 8 9
 
70.The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus
 

Clin Gastroenterol Hepatol. 2022 Mar 8;S1542-3565(22)00214-2.doi: 10.1016/j.cgh.2022.02.056. Online ahead of print.

Jennifer R Kramer 1, Peter A Richardson 1, Hyunseok Kim 2, Yao-Chun Hsu 2, Fasiha Kanwal 3, Hashem B El-Serag 4
 
71.Incidence of malignancies among patients with chronic hepatitis B in US health care organizations, 2006-2018
 

J Infect Dis. 2022 Jan 17;jiac011. doi: 10.1093/infdis/jiac011. Online ahead of print.

Philip R Spradling 1, Jian Xing 1, Y Zhong 1, Loralee B Rupp 2, Anne C Moorman 1, Mei Lu 2, Eyasu H Teshale 1, Mark A Schmidt 3, Yihe G Daida 4, Joseph A Boscarino 5, Stuart C Gordon 2 6, Chronic Hepatitis Cohort Study (CHeCS) Investigators
 
72.Immunological Biomarker Discovery in Cure Regimens for Chronic Hepatitis B Virus Infection
 

J Hepatol. 2022 Mar 5;S0168-8278(22)00127-1. doi: 10.1016/j.jhep.2022.02.020.Online ahead of print.

Adam J Gehring 1, Patricia Mendez 2, Kirsten Richter 3, Hildegund Ertl 4, Eric F Donaldson 5, Poonam Mishra 5, Mala Maini 6, Andre Boonstra 7, Georg Lauer 8, An de Creus 9, Kathleen Whitaker 10, Sara Ferrando Martinez 11, Jessica Weber 12, Emily Gainor 12, Veronica Miller 12
 
73.Protection and Antibody Levels 35 Years after Primary Series with Hepatitis B Vaccine and Response to a Booster Dose
 

Hepatology. 2022 Mar 23. doi: 10.1002/hep.32474. Online ahead of print.

Michael G Bruce 1, Dana Bruden 1, Debby Hurlburt 1, Julie Morris 1, Sara Bressler 1, Gail Thompson 1, Danielle Lecy 1, Karen Rudolph 1, Lisa Bulkow 1, Thomas Hennessy 1, Brenna C Simons 1, Mark K Weng 2, Noele Nelson 2, Brian J McMahon 1 3
 
74.Review article: hepatitis B-current and emerging therapies
 

Aliment Pharmacol Ther. 2022 Apr;55(7):805-819. doi: 10.1111/apt.16828.Epub 2022 Feb 27.

David Yardeni 1, Marc G Ghany 1
 
75.Immunological Biomarker Discovery in Cure Regimens for Chronic Hepatitis B Virus Infection
 

J Hepatol. 2022 Mar 5;S0168-8278(22)00127-1. doi: 10.1016/j.jhep.2022.02.020.Online ahead of print.

Adam J Gehring 1, Patricia Mendez 2, Kirsten Richter 3, Hildegund Ertl 4, Eric F Donaldson 5, Poonam Mishra 5, Mala Maini 6, Andre Boonstra 7, Georg Lauer 8, An de Creus 9, Kathleen Whitaker 10, Sara Ferrando Martinez 11, Jessica Weber 12, Emily Gainor 12, Veronica Miller 12
 
76.Protection and Antibody Levels 35 Years after Primary Series with Hepatitis B Vaccine and Response to a Booster Dose
 

Hepatology. 2022 Mar 23. doi: 10.1002/hep.32474. Online ahead of print.

Michael G Bruce 1, Dana Bruden 1, Debby Hurlburt 1, Julie Morris 1, Sara Bressler 1, Gail Thompson 1, Danielle Lecy 1, Karen Rudolph 1, Lisa Bulkow 1, Thomas Hennessy 1, Brenna C Simons 1, Mark K Weng 2, Noele Nelson 2, Brian J McMahon 1 3
 
77.Review article: hepatitis B-current and emerging therapies
 

Aliment Pharmacol Ther. 2022 Apr;55(7):805-819. doi: 10.1111/apt.16828.Epub 2022 Feb 27.

David Yardeni 1, Marc G Ghany 1
 
78.Serological testing on the ADVIA Centaur system for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in specimens from deceased and living individuals demonstrates equivalent results l
 

Transpl Infect Dis. 2022 Feb 17;e13802. doi: 10.1111/tid.13802. Online ahead of print.

Theodore B Wright 1, Sai Patibandla 1, Renee Walsh 1, Rachel Fonstad 1, Matthew Gee 1, Vera Bitcon 1, Julie Hopper 2, Susie J Braniff 3, Susan Best 3, Scott Read 4
 
79.Assessing the cost-utility of universal hepatitis B vaccination among adults
 

J Infect Dis. 2022 Mar 9;jiac088. doi: 10.1093/infdis/jiac088. Online ahead of print.

Eric W Hall 1 2, Mark K Weng 3, Aaron M Harris 3, Sarah Schillie 4, Noele P Nelson 3, Ismael R Ortega-Sanchez 4, Elizabeth Rosenthal 5, Patrick S Sullivan 2, Ben Lopman 2, Jeb Jones 2, Heather Bradley 6, Eli S Rosenberg 5 7
 
80.Aspirin Use and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B With or Without Cirrhosis
 

Hepatology. 2022 Jan 31. doi: 10.1002/hep.32380. Online ahead of print.

Heejoon Jang 1 2, Yun Bin Lee 1, Hyemi Moon 3, Jong-Won Chung 4, Joon Yeul Nam 1, Eun Ju Cho 1, Jeong-Hoon Lee 1, Su Jong Yu 1, Yoon Jun Kim 1, Juneyoung Lee 3, Jung-Hwan Yoon 1
 
81.Hepatitis B surface antigen and Hepatitis B RNA changes in HIV/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks
 

AIDS. 2022 Feb 14. doi: 10.1097/QAD.0000000000003193. Online ahead of print.

Claudia Hawkins 1, Minhee Kang, Debika Bhattacharya, Gavin Cloherty, Mary Kuhns, Roy Matining, Chloe Thio, Wadzanai Samaneka, Lameck Chinula, Nyirenda Mulinda, Sharlaa Badal-Faesen, Patcharaphan Sugandhavesa, Javier Lama, Simani Gaseitsiwe, Vera Holzmayer, Mark Anderson, Robert Murphy, Marion Peters
 
82.Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naïve Chronic Hepatitis B Patients
 

Dig Dis Sci. 2022 Mar 4. doi: 10.1007/s10620-022-07402-1. Online ahead of print.

Sammy Saab 1 2, Nguyen Pham 3, William Wu 3 4, Long Dang 3, An Dang 3, Jung Yum 3, Kisub Shim 3, Steven Wu 4
 
83.Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults
 

Dig Dis Sci. 2022 Feb;67(2):676-688. doi: 10.1007/s10620-021-06860-3. Epub 2021 Feb 8.

Richard K Sterling 1, Wendy C King 2, Mandana Khalili 3, David E Kleiner 4, Amanda S Hinerman 2, Mark Sulkowski 5, Raymond T Chung 6, Mamta K Jain 7, M Auricio Lisker-Melman 8, David K Wong 9, Marc G Ghany 4, HBV-HIV Cohort Study of the Hepatitis B Research Network
 
84.Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada
 

J Pediatr. 2021 Oct;237:24-33.e12. doi: 10.1016/j.jpeds.2021.05.035.Epub 2021 May 20.

Simon C Ling 1, Hsing-Hua S Lin 2, Karen F Murray 3, Philip Rosenthal 4, Douglas Mogul 5, Norberto Rodriguez-Baez 6, Sarah Jane Schwarzenberg 7, Jeffrey Teckman 8, Kathleen B Schwarz 5, Hepatitis B Research Network (HBRN)

Hepatitis B Research Network (HBRN): 

Hongxia Li, Robert Anders, Hejab Imteyaz, Peter Lee, Kiyoko Oshima, Kim Kafka, Naureen Islam, Shannon M Riggs, Rosemary A Nagy, Jacki Cerkoski, Athena Hau, Daniel Cui, Laurie A Rodgers-Augustyniak, Shirley Montanye, Natasha Feier, Joel Feier, Camille Langlois, Kara L Cooper, Jay H Hoofnagle, Averell H Sherker, Edward Doo, Rebecca J Torrance, Sherry R Hall, Frani Averbach, Tamara Haller, Regina Hardison, Stephanie Kelley, Christina M Lalama, Sharon Lawlor, Manuel Lombardero, Andrew Pelesko, Donna Stoliker, Melissa Weiner, Ella Zadorozny, Qian Zhao
 
85.Changes in serum hepatitis B surface and e antigen, IP-10, and aminotransferase levels during combination therapy of immune tolerant chronic hepatitis B
 

Hepatology. 2022 Feb 21. doi: 10.1002/hep.32400. Online ahead of print.

Robert P Perrillo 1, Hsing-Hua S Lin 2, Kathleen B Schwarz 3, Philip Rosenthal 4, Mauricio Lisker-Melman 5, Raymond T Chung 6, Ludmila Prokunina-Olsson 7, Gavin Coherty 8, Jordan Feld 9, Hepatitis B Research Network (HBRN)
 
86.Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B
 

Hepatology. 2022 Jan 24. doi: 10.1002/hep.32352. Online ahead of print.

Robin Erken 1 2, Vladimir Loukachov 1, Karel van Dort 1, Anne van den Hurk 1, R Bart Takkenberg 2, Anniki de Niet 2, Louis Jansen 2, Sophie Willemse 2, Henk Reesink 3, Neeltje Kootstra 1
 
87.Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014
 

Infect Control Hosp Epidemiol. 2021 Dec;42(12):1458-1463. doi: 10.1017/ice.2021.31.Epub 2021 Mar 1.

Stacy R Tressler 1, Maria C Del Rosario 1, Michelle D Kirby 2, Ashley N Simmons 1, Melissa A Scott 1, Sherif Ibrahim 1, Joseph C Forbi 3, Hong Thai 3, Guo-Liang Xia 3, Meghan Lyman 4, Melissa G Collier 3, Priti R Patel 4, Danae Bixler 1
 
88.Evaluation of dried blood spots for hepatitis B and D serology and nucleic acid testing
 

J Med Virol. 2022 Feb;94(2):642-648. doi: 10.1002/jmv.25485. Epub 2019 Apr 24.

Kathy Jackson 1, Thomas Holgate 1, Rosemary Tekoaua 2, Suellen Nicholson 1, Margaret Littlejohn 1, Stephen Locarnini 1
 
89.Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
 

J Hepatol. 2022 Jan 26;S0168-8278(22)00020-4. doi: 10.1016/j.jhep.2022.01.007.Online ahead of print.

M J Sonneveld 1, S-M Chiu 2, J Y Park 3, S M Brakenhoff 4, A Kaewdech 5, W K Seto 6, Y Tanaka 7, I Carey 8, M Papatheodoridi 9, F van Bömmel 10, T Berg 11, F Zoulim 12, S H Ahn 13, G N Dalekos 14, N S Erler 15, C Höner Zu Siederdissen 16, H Wedemeyer 17, M Cornberg 18, M F Yuen 19, K Agarwal 20, A Boonstra 21, M Buti 22, T Piratvisuth 23, G Papatheodoridis 24, C-H Chen 25, B Maasoumy 26, CREATE study group
 
90.The Possible Protective Effect of Hepatitis B Vaccine Against Lymphomas: A Systematic Review
 

Curr Pharm Biotechnol. 2022 Jan 13. doi: 10.2174/1389201023666220113111946.Online ahead of print.

Lorenza Lia 1, Daniela Grima 1, Francesca Amici 1, Linda Manzi 1, Alessandro Monaci 1, Giuseppe La Torre 1
 
91.Envafolimab: First Approval
 

Drugs. 2022 Feb;82(2):235-240. doi: 10.1007/s40265-022-01671-w.

Anthony Markham 1
 
92.An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States
 

Hepatology. 2021 Aug;74(2):607-626. doi: 10.1002/hep.31782.Epub 2021 May 26.

Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
 
93.Getting to HBV cure: the promising paths forward
 

Hepatology. 2022 Jan 6. doi: 10.1002/hep.32314. Online ahead of print.

Scott Fung 1, Hannah S J Choi 1, Adam Gehring 1, Harry L A Janssen 1
 
94.Documentation of Hepatitis B Immunity in Nursing Students
 

Nurs Educ Perspect. 2022 Jan-Feb 01;43(1):55-56. doi: 10.1097/01.NEP.0000000000000736.

Julie Kientz Elting 1
 
95.Hepatitis B vaccine coverage and risk factors for lack of vaccination in subjects with HBsAg negative liver cirrhosis in Italy: still, much work should be done
 

Dig Liver Dis. 2021 Oct;53(10):1315-1319. doi: 10.1016/j.dld.2020.10.011. Epub 2020 Nov 6.

Tommaso Stroffolini 1, Anna Lombardi 2, Alessia Ciancio 3, Rosanna Fontana 4, Guido Colloredo 5, Massimo Marignani 6, Maria Vinci 7, Filomena Morisco 8, Sergio Babudieri 9, Luigina Ferrigno 10, Evangelista Sagnelli 11
 
96.Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease
 

Dig Dis Sci. 2021 Jun;66(6):2101-2106.doi: 10.1007/s10620-020-06437-6. Epub 2020 Jul 2.

Waseem Amjad 1, Joseph Alukal 1, Talan Zhang 1, Anurag Maheshwari 1 2, Paul J Thuluvath 3 4
 
97.Moving towards core antigen for the management of patients with overt and occult HBV infection
 

Panminerva Med. 2021 Dec;63(4):499-507. doi: 10.23736/S0031-0808.20.04163-4.Epub 2020 Oct 19.

Angelo Armandi 1, Chiara Rosso 1, Davide G Ribaldone 1 2, Gian P Caviglia 3
 
98.Talking testing: Impact of a training intervention on midwives' antenatal HIV, hepatitis B and hepatitis C screening practice
 

Women Birth. 2021 Sep;34(5):e520-e525. doi: 10.1016/j.wombi.2020.10.001. Epub 2020 Nov 4.

Jen Johnson 1, Caroline Carr 2, Susan J McDonald 3, Margaret M Flood 4
 
99.Human Papillomavirus, Herpes Zoster, and Hepatitis B Vaccinations in Immunocompromised Patients: An Update for Pharmacists
 

J Pharm Pract. 2021 Dec;34(6):943-951. doi: 10.1177/0897190020958261.Epub 2020 Sep 17.

Michelle R Paulsen 1, Nikitha R Patel 2, Carol Sulis 3, Francis A Farraye 4, Shubha Bhat 2
 
100.Rapid, random-access, and quantification of hepatitis B virus using the Cepheid Xpert HBV viral load assay
 

Med Virol. 2021 Jun;93(6):3999-4003. doi: 10.1002/jmv.26392. Epub 2020 Aug 25.

Ali M Auzin 1, Serena Slavenburg 2, Cas Peters 1, Greet Boland 2, Janette Rahamat-Langendoen 1, Willem J G Melchers 1, Rob Schuurman 2
 
101.Critical Updates on Chronic Hepatitis B Virus Infection in 2021
 

Cureus. 2021 Oct 30;13(10):e19152. doi: 10.7759/cureus.19152.eCollection 2021 Oct.

Cyriac A Philips 1, Rizwan Ahamed 2, Jinsha K Abduljaleel 2, Sasidharan Rajesh 3, Philip Augustine 2
 
102.Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial
 

Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.

Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
 
103.New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection
 

Clin Liver Dis. 2021 Nov;25(4):831-839. doi: 10.1016/j.cld.2021.06.011.Epub 2021 Aug 8.

Lisa Sandmann 1, Heiner Wedemeyer 2
 
104.Critical Updates on Chronic Hepatitis B Virus Infection in 2021
 

Cureus. 2021 Oct 30;13(10):e19152. doi: 10.7759/cureus.19152.eCollection 2021 Oct.

Cyriac A Philips 1, Rizwan Ahamed 2, Jinsha K Abduljaleel 2, Sasidharan Rajesh 3, Philip Augustine 2
 
105.Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial
 

Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.

Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
 
106.New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection
 

Clin Liver Dis. 2021 Nov;25(4):831-839. doi: 10.1016/j.cld.2021.06.011.Epub 2021 Aug 8.

Lisa Sandmann 1, Heiner Wedemeyer 2
 
107.Should Treatment Indications for Chronic Hepatitis B Be Expanded?
 

Clin Gastroenterol Hepatol. 2021 Oct;19(10):2006-2014.doi: 10.1016/j.cgh.2020.04.091. Epub 2020 May 17.

Wen-Juei Jeng 1, Anna S Lok 2
 
108.Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients
 

J Rheumatol. 2021 Aug;48(8):1314-1321. doi: 10.3899/jrheum.200283. Epub 2020 Aug 1.

Najla Aljaberi 1, Enas Ghulam 2, Emily A Smitherman 3, Leslie Favier 4, Dana M H Dykes 5, Lara A Danziger-Isakov 6, Rebecca C Brady 6, Jennifer Huggins 7
 
109.Circulating Pregenomic Hepatitis B Virus RNA Is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy
 

Clin Infect Dis. 2021 Jun 1;72(11):2029-2031. doi: 10.1093/cid/ciaa1015.

Mark Anderson 1, Jeffery Gersch 1, Ka-Cheung Luk 1, George Dawson 1, Ivana Carey 2, Kosh Agarwal 3, Pir Shah 4, Geoffrey Dusheiko 3, Daryl Lau 4, Gavin Cloherty 1
 
110.Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection
 

Clin Gastroenterol Hepatol. 2021 Sep;19(9):1933-1940.e1. doi: 10.1016/j.cgh.2020.09.004.Epub 2020 Sep 3.

Hannah S J Choi 1, Margo J H van Campenhout 2, Anneke J van Vuuren 2, Lisette A P Krassenburg 3, Milan J Sonneveld 2, Robert J de Knegt 2, Bettina E Hansen 4, Harry L A Janssen 5
 
111.Use of Electronic Health Records at Federally Qualified Health Centers: a Potent Tool to Increase Viral Hepatitis Screening and Address the Climbing Incidence of Liver Cancer
 

J Cancer Educ. 2021 Oct;36(5):1093-1097. doi: 10.1007/s13187-020-01741-1.

Christina Pham 1, Mo-Kyung Sin 2
 
112.Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over Time
 

Hepatology. 2021 Jun;73(6):2141-2154. doi: 10.1002/hep.31557. Epub 2021 Jun 15.

Lauren Lapointe-Shaw 1 2 3 4 5, Hannah Chung 3, Laura Holder 3, Jeffrey C Kwong 3 4 6 7 8, Beate Sander 2 3 4 6 9 10, Peter C Austin 3 10, Harry L A Janssen 1 2 4 11, Jordan J Feld 1 2 4 11
 
113.Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy
 

Hepatology. 2021 Jun;73(6):2124-2140. doi: 10.1002/hep.31554. Epub 2021 May 21.

Anna S Lok 1, Robert Perrillo 2, Christina M Lalama 3, Michael W Fried 4, Steven H Belle 5, Marc G Ghany 6, Mandana Khalili 7, Robert J Fontana 1, Richard K Sterling 8, Norah Terrault 9, Jordan J Feld 10, Adrian M Di Bisceglie 11, Daryl T Y Lau 12, Mohamed Hassan 13, Harry L A Janssen 14, Hepatitis B Research Network (HBRN)
 
114.Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems
 

Am J Gastroenterol. 2021 Jul 1;116(7):1465-1475. doi: 10.14309/ajg.0000000000001195.

Robert J Wong 1 2 3, Mamta K Jain 4 5, George Therapondos 6, Bolin Niu 7, Onkar Kshirsagar 8, Mae Thamer 8
 
115.Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection
 

Intern Emerg Med. 2021 Sep 2. doi: 10.1007/s11739-021-02836-3. Online ahead of print.

Michele Barone 1, Vincenzo Venerito 2, Rosa Paolillo 1, Giacomo Emmi 3, Marco Fornaro 2, Fabio Cacciapaglia 2, Luca Cantarini 4, Alfredo Di Leo 1, Florenzo Iannone 2, Giuseppe Lopalco 5
 
116.Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
 

Front Med (Lausanne). 2021 Aug 20;8:706482. doi: 10.3389/fmed.2021.706482.eCollection 2021.

Cori Campbell 1, Monique I Andersson 2 3, M Azim Ansari 1 4, Olivia Moswela 5, Siraj A Misbah 6, Paul Klenerman 1 2, Philippa C Matthews 1 2
 
117.Towards eradication of HBV: Treatment approaches and status of clinical trials
 

Curr Opin Pharmacol. 2021 Aug 30;60:232-240. doi: 10.1016/j.coph.2021.07.008.Online ahead of print.

Lisa Sandmann 1, Markus Cornberg 2
 
118.Hepadnaviral Lymphotropism and Its Relevance to HBV Persistence and Pathogenesis
 

Front Microbiol. 2021 Aug 6;12:695384. doi: 10.3389/fmicb.2021.695384.eCollection 2021.

Carla S Coffin 1, Patricia M Mulrooney-Cousins 2, Tomasz I Michalak 2
 
119.Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B
 

GastroHep. 2021 May;3(3):196-208. doi: 10.1002/ygh2.458. Epub 2021 May 5.

Donna M Evon 1, Hsing-Hua S Lin 2, Robert J Fontana 3, Mandana Khalili 4, Colina Yim 5, Abdus S Wahed 2, Jay H Hoofnagle 6
 
120.Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update
 

Clin Gastroenterol Hepatol. 2021 Jul 27;S1542-3565(21)00818-1. doi: 10.1016/j.cgh.2021.07.036.Online ahead of print.

Paul Martin 1, Mindie H Nguyen 2, Douglas T Dieterich 3, Daryl T-Y Lau 4, Harry L A Janssen 5, Marion G Peters 6, Ira Jacobson 7
 
121.Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals
 

Aliment Pharmacol Ther. 2021 Jul 19. doi: 10.1111/apt.16524. Online ahead of print.

Jill Koshiol 1, Ilona Argirion 1, Zhiwei Liu 1, Tram Kim Lam 2, Thomas R O'Brien 1, Kelly Yu 1, Katherine A McGlynn 1, Jessica L Petrick 1 3, Ligia Pinto 4, Chien-Jen Chen 5 6, Allan Hildesheim 1, Ruth M Pfeiffer 1, Mei-Hsuan Lee 7, Hwai-I Yang 5
 
122.The Inflammatory Cytokine Profile Associated with Liver Damage is Broader and Stronger in Chronic Hepatitis B Patients Compared to Acute Hepatitis B Patients
 

J Infect Dis. 2021 Jul 21;jiab373. doi: 10.1093/infdis/jiab373. Online ahead of print.

Alexandra Johnson Valiente 1 2, Kin Seng Liem 2 3, Kathleen B Schwarz 4 5, Philip Rosenthal 6, Karen F Murray 7, Douglas Mogul 5, Jeffery Teckman 8, Norberto Rodriguez-Baez 9, Sarah Jane Schwarzenberg 10, Jordan J Feld 2 11, David K Wong 2, Lia L Lewis-Ximenez 12, Georg Lauer 13, Bettina E Hansen 2 14, Simon C Ling 15 16, Harry L A Janssen 2 11, Adam J Gehring 1 2 11
 
123.Hepatitis B Virus (HBV) Genotype: A Significant Risk Factor in Determining which Patients with Chronic HBV Infection should Undergo Surveillance for Hepatocellular Carcinoma: The Hepatitis B Alaska (HEP-B-AK) Study
 

Hepatology. 2021 Jul 22. doi: 10.1002/hep.32065. Online ahead of print.

Brian J McMahon 1 2, Solu Nolen 2, Mary Snowball 1, Chriss Homan 1, Susan Negus 1, Elena Roik 1, Philip R Spradling 3, Dana Bruden 2
 
124.Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus
 

Pharmacoepidemiol Drug Saf. 2021 Jul 10. doi: 10.1002/pds.5327. Online ahead of print.

Katherine Wong 1, Katia Bruxvoort 1, Jeff Slezak 1, Jin-Wen Y Hsu 1, Kristi Reynolds 1, Lina S Sy 1, Steven J Jacobsen 1
 
125.Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma
 

 

BMJ Case Rep. 2021 Jul 9;14(7):e243526. doi: 10.1136/bcr-2021-243526.

Branko Borojevic 1, Ayushi Chauhan 2, Scott Patterson 3
 
126.Hepatitis B Screening of At-Risk Immigrants Seen at Primary Care Clinics: A Quality Improvement Project
 

Mayo Clin Proc Innov Qual Outcomes. 2021 May 27;5(3):635-644.doi: 10.1016/j.mayocpiqo.2021.04.002. eCollection 2021 Jun.

Peace N Eneh 1, Mohamed Mady 1, Mikayla A Schmidt 1, Eneyew Tilahun 1, Fatima Hassan 1, Jane W Njeru 2, Sarah J Crane 2, Rajeev Chaudhry 2, Lewis R Roberts 1
 
127.Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine example
 

Vaccine X. 2021 Jun 11;8:100101. doi: 10.1016/j.jvacx.2021.100101. eCollection 2021 Aug.

Katia Bruxvoort 1, Lina S Sy 1, Bradley K Ackerson 1, Jeff Slezak 1, Lei Qian 1, William Towner 1, Kristi Reynolds 1, Zendi Solano 1, Cheryl M Carlson 1, Steven J Jacobsen 1
 
128.A Deep Ravine Rather Than a Shallow Gap: Many More Bridges Needed to Improve Care of Chronic Hepatitis B in the United States
 

Am J Gastroenterol. 2021 Jun 30. doi: 10.14309/ajg.0000000000001364. Online ahead of print.

Esperance A K Schaefer 1
 
129.Estimated prevalence and number of persons with isolated antibody to hepatitis B core antigen and associated occult hepatitis B, United States, 2001-2018
 

J Infect Dis. 2021 Jul 12;jiab366. doi: 10.1093/infdis/jiab366. Online ahead of print.

Philip R Spradling 1, Jian Xing 1, Aaron M Harris 1, Kathleen N Ly 1
 
130.Moving Fast Toward Hepatitis B Virus Elimination
 

Adv Exp Med Biol. 2021;1322:115-138. doi: 10.1007/978-981-16-0267-2_5.

Leda Bassit # 1, Suzane Kioko Ono # 2, Raymond F Schinazi 3
 
131.Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019
 

MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):961-966. doi: 10.15585/mmwr.mm7027a1.

Danae Bixler, Pallavi Annambhotla, Martha P Montgomery, Tonya Mixon-Hayden, Ben Kupronis, Marian G Michaels, Ricardo M La Hoz, Sridhar V Basavaraju, Saleem Kamili, Anne Moorman
 
132.Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States
 

J Immigr Minor Health. 2021 Jun 23. doi: 10.1007/s10903-021-01231-6.Online ahead of print.

Amit S Chitnis 1, Ramsey Cheung 2 3, Robert G Gish 4, Robert J Wong 2 3
 
133.Family imaginaries in the disclosure of a blood-borne virus
 

Sociol Health Illn. 2021 Jun 23. doi: 10.1111/1467-9566.13316. Online ahead of print.

Anthony K J Smith 1, Asha Persson 1, Kerryn Drysdale 1 2, Joanne Bryant 1, Kylie Valentine 3, Jack Wallace 4, Myra Hamilton 5, Rebecca M Gray 1, Christy E Newman 1
 
134.Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
 

BMC Infect Dis. 2021 Jun 26;21(1):610. doi: 10.1186/s12879-021-06226-0.

Tingyan Wang 1 2, David A Smith 2 3, Cori Campbell 1 2, Jolynne Mokaya 1, Oliver Freeman 2 4, Hizni Salih 2 4, Anna L McNaughton 1, Sarah Cripps 5, Kinga A Várnai 2 3, Theresa Noble 2 3, Kerrie Woods 2 3, Jane Collier 6, Katie Jeffery 7, Jim Davies 2 8, Eleanor Barnes # 9 10, Philippa C Matthews # 11 12 13
 
135.Hepatitis B cure: How and when
 

Liver Int. 2021 Jun;41 Suppl 1:24-29.doi: 10.1111/liv.14837.

Geoffrey Dusheiko 1
 
136.Comparison of Novel Biomarkers with Conventional HBV Markers among Untreated Adults with Chronic Hepatitis B in North America
 

Hepatology. 2021 Jun 16. doi: 10.1002/hep.32018. Online ahead of print.

Marc G Ghany 1, Wendy C King 2, Mauricio Lisker-Melman 3, Anna Sf Lok 4, Norah Terrault 5, Harry L A Janssen 6, Mandana Khalili 7, Raymond T Chung 8, William M Lee 9, Daryl T Y Lau 10, Gavin A Cloherty 11, Richard K Sterling 12
 
137.Hepatitis B infections among blood donors in England between 2009 and 2018: Is an occult hepatitis B infection a risk for blood safety?
 

Transfusion. 2021 Jun 11. doi: 10.1111/trf.16543. Online ahead of print.

Heli Harvala 1 2, Claire Reynolds 3, Zoë Gibney 4, Jade Derrick 5, Samreen Ijaz 5, Katy L Davison 4, Su Brailsford 1 3
 
138.Hepatitis B and Hepatitis C among Adults on Probation or Parole in the United States: 2015-2018
 

J Health Care Poor Underserved. 2021;32(2):671-679. doi: 10.1353/hpu.2021.0096.

Greta Kilmer, Elizabeth Hughes
 
139.Prevalence of Hepatitis B Virus (HBV) Infection, Vaccine-Induced Immunity, and Susceptibility among At-Risk Populations: U.S. Households, 2013-2018
 

Hepatology. 2021 Jun 7. doi: 10.1002/hep.31991. Online ahead of print.

Henry Roberts 1, Kathleen N Ly 1, Shaoman Yin 1, Elizabeth Hughes 1, Eyasu Teshale 1, Ruth Jiles 1
 
140.Covalently closed circular DNA: the ultimate therapeutic target for curing Hepatitis B virus infections
 

J Hepatol. 2021 May 26;S0168-8278(21)00348-2. doi: 10.1016/j.jhep.2021.05.013.Online ahead of print.

Maria Guadalupe Martinez 1, Anders Boyd 2, Emmanuel Combe 1, Barbara Testoni 1, Fabien Zoulim 3
 
141.Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV
 

Dig Dis Sci. 2021 May 31. doi: 10.1007/s10620-021-07033-y. Online ahead of print.

David E Bernstein 1, Huy N Trinh 2, Eugene R Schiff 3, Coleman I Smith 4, Andrea R Mospan 5, Richard C Zink 5, Michael W Fried 5, Anna S Lok 6
 
142.Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study
 

BMC Public Health. 2021 May 28;21(1):1004. doi: 10.1186/s12889-021-11093-0.

Catherine Freeland 1 2, Sean Farrell 3 4, Priyanka Kumar 3 5, Maureen Kamischke 6, Michaela Jackson 6, Sierra Bodor 6, Timothy M Block 6, Rosemary Frasso 3, Chari Cohen 6
 
143.An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States
 

Hepatology. 2021 Mar 3. doi: 10.1002/hep.31782. Online ahead of print.

Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
 
144.Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems
 

J Clin Gastroenterol. 2021 Mar 17. doi: 10.1097/MCG.0000000000001530. Online ahead of print.

Robert J Wong 1, Mamta K Jain, George Therapondos, Bolin Niu, Onkar Kshirsagar, Mae Thamer
 
145.Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver Disease
 

Am J Med. 2021 Mar 26;S0002-9343(21)00159-5. doi: 10.1016/j.amjmed.2021.02.008. Online ahead of print.

Robert J Wong 1, Robert G Gish 2, Ramsey Cheung 3, Amit S Chitnis 4
 
146.Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems
 

Am J Gastroenterol. 2021 Mar 1. doi: 10.14309/ajg.0000000000001195. Online ahead of print.

Robert J Wong 1, Mamta K Jain, George Therapondos, Bolin Niu, Onkar Kshirsagar, Mae Thamer
 
147.Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis
 

J Clin Gastroenterol. 2021 Apr 9. doi: 10.1097/MCG.0000000000001533. Online ahead of print.

Robert J Wong 1, Ashley Hubbard, Laurie Bagley, Rita Shiau, Amit S Chitnis
 
148.Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C
 

J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13545. Online ahead of print.

Erika Duffell 1, Helena Cortez-Pinto 2, Marieta Simonova 3, Olav Dalgard 4, Elin Hoffmann Dahl 5, Catherine de Martel 6, Antons Mozalevskis 7, Maria Buti 8, Slava Pavlova 3, Tnaiq Hadzhilova 3, Carolina Simões 2, Krum Katzarov 3, Otilia Mardh 1
 
149.Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls
 

Nephrol Dial Transplant. 2021 May 17;gfab179. doi: 10.1093/ndt/gfab179. Online ahead of print.

Benedikt Simon 1, Harald Rubey 1, Andreas Treipl 2, Martin Gromann 2, Boris Hemedi 3, Sonja Zehetmayer 4, Bernhard Kirsch 2
 
150.Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study
 

Int J Dermatol. 2021 May 17. doi: 10.1111/ijd.15578. Online ahead of print.

Jeffrey M Cohen 1, Khalaf K Kridin 2, Lourdes M Perez-Chada 3, Joseph F Merola 3 4, Arnon D Cohen 5 6
 
151.Therapeutic vaccination for treatment of Chronic Hepatitis B
 

Clin Exp Immunol. 2021 May 9. doi: 10.1111/cei.13614. Online ahead of print.

Tamsin Cargill 1 2, Eleanor Barnes 1 2 3
 
152.High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities
 

Microorganisms. 2021 Apr 30;9(5):968. doi: 10.3390/microorganisms9050968.

Jan-Hendrik Bockmann 1 2, Matin Kohsar 1, John M Murray 3, Vanessa Hamed 1, Maura Dandri 1 2, Stefan Lüth 4, Ansgar W Lohse 1 2, Julian Schulze-Zur-Wiesch 1 2

 
 
153.Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States
 

Clin Infect. 2021 May 6;ciab405.doi: 10.1093/cid/ciab405. Online ahead of print.

Mehlika Toy 1, David Hutton 2, Aaron M Harris 3, Noele Nelson 3, Joshua A Salomon 4, Samuel So 1
 
154.Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults
 

Dig Dis Sci. 2021 May 4. doi: 10.1007/s10620-021-07008-z. Online ahead of print.

Wen-Qiang He 1, Gail V Matthews 2, Bette Liu 3
 
155.Challenges in Formulation and Implementation of Hepatitis B Elimination Programs
 

Cureus. 2021 Apr 24;13(4):e14657. doi: 10.7759/cureus.14657.

Zaigham Abbas 1, Minaam Abbas 2
 
156.Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity
 

Mol Ther Methods Clin Dev. 2021 Mar 23;21:288-298. doi:10.1016/j.omtm.2021.03.012.eCollection 2021 Jun 11.

Gounwa Awad 1, Toralf Roch 1 2, Ulrik Stervbo 1, Sviatlana Kaliszczyk 1 2, Anna Stittrich 2 3, Jan Hörstrup 4, Ocan Cinkilic 5, Heiner Appel 6, Larysa Natrus 7, Ludmila Gayova 7, Felix Seibert 1, Frederic Bauer 1, Timm Westhoff 1, Mikalai Nienen 2 3 8, Nina Babel 1 2
 
157.Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018
 

J Infect Dis. 2021 Apr 27;jiab224. doi: 10.1093/infdis/jiab224. Online ahead of print.

Kathleen N Ly 1, Jian Xing 1, Philip R Spradling 1
 
158.Clinical Significance of Quantitative e Antigen in a Cohort of Hepatitis B Virus Infected Children and Adults in North America
 

J Viral Hepat. 2021 Apr 24. doi: 10.1111/jvh.13520. Online ahead of print.

Stewart L Cooper 1, Wendy C King 2, Douglas B Mogul 3, Marc G Ghany 4, Kathleen B Schwarz 3, Hepatitis B Research Network (HBRN)

 

  • Hepatitis B Research Network (HBRN): 

Daryl T-Y Lau, Raymond T Chung, Lewis R Roberts, Mohamed A Hassan, Sarah Jane Schwarzenberg, Adrian M Di Bisceglie, Mauricio Lisker-Melman, Jeffrey Teckman, Harry L A Janssen, David K Wong, Joshua Juan, Jordan Feld, Colina Yim, Keyur Patel, Simon C Ling, William M Lee, Carol S Murakami, Robert Perrillo, Son Do, Norberto Rodriguez-Baez, Steven-Huy B Han, Tram T Tran, Norah A Terrault, Mandana Khalili, Philip Rosenthal, Anna Suk-Fong Lok, Robert J Fontana, Naoky Tsai, Barak Younoszai, Michael W Fried, Andrew Muir, Donna Evon, Jama M Darling, Robert C Carithers, Margaret Shuhart, Kris V Kowdley, Chia C Wang, Karen F Murray, Richard K Sterling, Velimir A Luketic, T Jake Liang, Jay H Hoofnagle, Edward Doo, Kyong-Mi Chang, Jang-June Park, Steven H Belle, Abdus Wahed, David Kleiner
 
159.Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
 

Wellcome Open Res. 2020 Jun 29;5:151. doi: 10.12688/wellcomeopenres.15992.1.eCollection 2020.

Jolynne Mokaya 1, Anna L McNaughton 1, Phillip A Bester 2, Dominique Goedhals 2, Eleanor Barnes 1 3 4, Brian D Marsden 5 6, Philippa C Matthews 1 4 7
 
160.Hepatitis B Reactivation: A Review of Clinical Guidelines
 

J Clin Gastroenterol. 2021 May-Jun 01;55(5):393-399. doi: 10.1097/MCG.0000000000001520.

Yun Wang 1, Steven-Huy B Han 2
 
161.Hepatitis D virus and liver transplantation: Indications and outcomes
 

World J Hepatol. 2021 Mar 27;13(3):291-299. doi: 10.4254/wjh.v13.i3.291.

Haris Muhammad 1, Aniqa Tehreem 2, Muhammad Baraa Hammami 3, Peng-Sheng Ting 3, Ramzan Idilman 4, Ahmet Gurakar 5
 
162.Hepatitis B Reactivation: A Review of Clinical Guidelines
 

J Clin Gastroenterol. 2021 May-Jun 01;55(5):393-399. doi: 10.1097/MCG.0000000000001520.

Yun Wang 1, Steven-Huy B Han 2
 
163.Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver Disease
 

Am J Med. 2021 Mar 25;S0002-9343(21)00159-5. doi: 10.1016/j.amjmed.2021.02.008.Online ahead of print.

Robert J Wong 1, Robert G Gish 2, Ramsey Cheung 3, Amit S Chitnis 4
 
164.Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy
 

Curr Hepatol Rep. 2020 Dec;19(4):345-353. doi: 10.1007/s11901-020-00541-x.Epub 2020 Sep 16.

H Nina Kim 1 2
 
165.Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B
 

J Viral Hepat. 2021 Mar 22. doi: 10.1111/jvh.13499. Online ahead of print.

Gerrit Post 1, Jess Howell 2, Amina Sow 3, Gibril Ndow 4, Isabelle Chemin 5, Gora Lo 3, Amie Cessay 4, Damien Cohen 5, Ramou Njie 6, Souleymane Toure 7, Madoky Diop 7, Roger Sombie 8, Jean Nana 9, Vincent Leroy 9, Karine Lacombe 10, Lamin Bojang 4, Frank Tacke 1, Coumba Toure-Kane 3, Mourtalla Ka 7, Maimuna Mendy 6, Souleymane Mboup 3, Mark Thursz 11, Yusuke Shimakawa 12, Patrick Ingiliz 1 13, Maud Lemoine 11
 
166.A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America
 

Hepatology. 2021 Mar 20. doi: 10.1002/hep.31823. Online ahead of print.

Richard K Sterling 1, Wendy C King 2, Mandana Khalili 3, Raymond T Chung 4, Mark Sulkowski 5, Mamta K Jain 6, Mauricio Lisker-Melman 7, Marc G Ghany 8, David K Wong 9, Amanda S Hinerman 2, Atul K Bhan 4, Abdus S Wahed 2, David E Kleiner 8, HIV-HBV Cohort Study of the Hepatitis B Research Network
 
167.Process and operations strategies to enable global access to antibody therapies
 

Biotechnol Prog. 2021 Mar 8;e3139. doi: 10.1002/btpr.3139. Online ahead of print.

Brian Kelley 1, Todd Renshaw 1, Michael Kamarck 1
 
168.Acceptability and Feasibility of Home-Based Hepatitis B Screening Among Haitian Immigrants
 

J Immigr Minor Health. 2021 Mar 9. doi: 10.1007/s10903-021-01165-z. Online ahead of print.

Patricia D Jones 1 2, Kristin Gmunder 3, Saradjine Batrony 3, Paul Martin 3 4, Erin Kobetz 3 5, Olveen Carrasquillo 3 6
 
169.Clinical and occupational health management of healthcare workers living with chronic hepatitis B: UK policy and international comparisons
 

J Viral Hepat. 2021 Mar 4. doi: 10.1111/jvh.13494. Online ahead of print.

Grace E Dolman 1, Apostolos Koffas 2, Emily Phipps 3, Patrick T F Kennedy 1
 
170.Multicenter Evaluation of the Cepheid Xpert ® HBV Viral Load Test
 

Diagnostics (Basel). 2021 Feb 12;11(2):297. doi: 10.3390/diagnostics11020297.

Fabbio Marcuccilli 1, Stephane Chevaliez 2, Thomas Muller 3, Luna Colagrossi 4, Giulia Abbondanza 1, Kurt Beyser 3, Mélanie Wlassow 2, Valérie Ortonne 2, Carlo Federico Perno 4, Marco Ciotti 1
 
171.Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver
 

Viruses. 2021 Jan 30;13(2):210.doi: 10.3390/v13020210.

William S Mason 1, Allison R Jilbert 2, Samuel Litwin 1
 
172.Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19
 

Immunol Rev. 2021 Feb 8. doi: 10.1111/imr.12953. Online ahead of print.

Alice R Burton 1, Mala K Maini 1
 
173.Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
 

Wellcome Open Res. 2021 Jan 25;5:240.doi: 10.12688/wellcomeopenres.16157.2. eCollection 2020.

Louise O Downs 1 2, Anna L McNaughton 2, Mariateresa de Cesare 3, M Azim Ansari 3, Jacqueline Martin 4, Charles Woodrow 1, Rory Bowden 3, Jane Collier 4, Eleanor Barnes 2 4 5, Philippa C Matthews 1 2 5
 
174.Urinary Polycyclic Aromatic Hydrocarbons Concentrations and Hepatitis B Antibody Serology in the United States (NHANES, 2003-2014)
 

Environ Res. 2021 Feb 1;110801. doi: 10.1016/j.envres.2021.110801. Online ahead of print.

Faye V Andrews 1, Ellen Smit 2, Barrett M Welch 3, Sharia M Ahmed 4, Molly L Kile 2
 
175.Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
 

Diagnostics (Basel). 2021 Jan 28;11(2):187. doi: 10.3390/diagnostics11020187.

Gian Paolo Caviglia 1, Angelo Armandi 1, Chiara Rosso 1, Davide Giuseppe Ribaldone 1, Rinaldo Pellicano 2, Sharmila Fagoonee 3
 
176.The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018
 

Sex Transm Dis. 2021 Jan 23. doi: 10.1097/OLQ.0000000000001380. Online ahead of print.

Harrell W Chesson 1, Ian H Spicknall, Adrienna Bingham, Marc Brisson, Samuel T Eppink, Paul G Farnham, Kristen M Kreisel, Sagar Kumar, Jean-François Laprise, Thomas A Peterman, Henry Roberts, Thomas L Gift
 
177.Incidence and Prevalence of Sexually Transmitted Hepatitis B, United States, 2013 – 2018
 

Sex Transm Dis. 2021 Jan 23. doi: 10.1097/OLQ.0000000000001359. Online ahead of print.

Henry Roberts 1, Ruth Jiles, Aaron M Harris, Neil Gupta, Eyasu Teshale
 
178.Hepatitis B Virus Reactivation in Cancer Patients Treated With Immune Checkpoint Inhibitors
 

J Immunother. 2021 Jan 19. doi: 10.1097/CJI.0000000000000358. Online ahead of print.

Ethan A Burns 1, Ibrahim N Muhsen, Kartik Anand, Jiaqiong Xu, Godsfavour Umoru, Abeer N Arain, Maen Abdelrahim
 
179.Test to Protect Family and Self-A Hepatitis B Screening and Care-Linkage Initiative in the Coastal Mississippi Vietnamese Community
 

J Health Care Poor Underserved. 2020;31(3):1228-1247. doi: 10.1353/hpu.2020.0091.

Tanya T Funchess, Danielle Fastring, Victor Sutton, Victoria Walker, Daniel Le
 
180.Improving Hepatitis B Care in the US: A Case for a New "Ryan White" Program
 

J Health Care Poor Underserved. 2020;31(3):1037-1043. doi: 10.1353/hpu.2020.0077.

Jonathan D Alpern, Thomas M Leventhal, Nathan C Bahr
 
181.The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
 

BMJ Glob Health. 2021 Jan;6(1):e004275. doi: 10.1136/bmjgh-2020-004275.

Caitlin M Pley 1, Anna L McNaughton 2, Philippa C Matthews 2 3, José Lourenço 4
 
182.Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)
 

NPJ Vaccines. 2021 Jan 11;6(1):9. doi: 10.1038/s41541-020-00266-4.

Shivali S Joshi 1, Rachelle P Davis 2, Mang M Ma 3, Edward Tam 4, Curtis L Cooper 5, Alnoor Ramji 6, Erin M Kelly 5, Saumya Jayakumar 1 7, Mark G Swain 1, Craig N Jenne 2, Carla S Coffin 8
 
183.Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study
 

Vaccine. 2021 Jan 12;S0264-410X(20)31630-3. doi: 10.1016/j.vaccine.2020.12.050.Online ahead of print.

Jacob Atsmon 1, Nathalie Machluf 2, Vered Yagon-Gur 2, Cyril Sabbah 2, Johanna N Spaans 3, Bebi Yassin-Rajkumar 3, David E Anderson 3, Vlad Popovic 3, Francisco Diaz-Mitoma 4
 
184.The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups
 

Int J Epidemiol. 2020 Dec 27;dyaa253. doi: 10.1093/ije/dyaa253. Online ahead of print.

Nora Schmit 1, Shevanthi Nayagam 1 2, Mark R Thursz 2, Timothy B Hallett 1
 
185.Adherence to pregnancy hepatitis B care guidelines in women and infants in the and evaluation of two interventions to improve care: a multi-center hospital-based study
 

J Viral Hepat. 2020 Dec 29. doi: 10.1111/jvh.13459. Online ahead of print.

Tatyana Kushner 1, Elianna Kaplowitz 2, Rena Mei 3, Chelsea Xu 4, Alex Acker 5, Emma Rosenbluth 1, Igbagbosanmi Oredein 4, Monika Sarkar 4, Norah Terrault 6, Meena Bansal 1, Kimberly A Forde 7 8
 
186.Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
 

JAMA. 2020 Dec 15;324(23):2423-2436. doi: 10.1001/jama.2020.19750.

Roger Chou 1 2, Ian Blazina 1, Christina Bougatsos 1, Rebecca Holmes 1, Shelley Selph 1 3, Sara Grusing 1, Janice Jou 1 4
 
187.Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement
 

JAMA. 2020 Dec 15;324(23):2415-2422. doi: 10.1001/jama.2020.22980.

US Preventive Services Task Force; Alex H Krist 1 2, Karina W Davidson 3, Carol M Mangione 4, Michael J Barry 5, Michael Cabana 6, Aaron B Caughey 7, Katrina Donahue 8, Chyke A Doubeni 9, John W Epling Jr 10, Martha Kubik 11, Gbenga Ogedegbe 12, Douglas K Owens 13, Lori Pbert 14, Michael Silverstein 15, Melissa A Simon 16, Chien-Wen Tseng 17 18, John B Wong 19
 
188.Development and validation of a hepatitis B-specific health-related quality of life instrument: CLDQ-HBV
 

J Viral Hepat. 2020 Dec 11. doi: 10.1111/jvh.13451. Online ahead of print.

Zobair M Younossi 1, Maria Stepanova 2, Issah Younossi 2, Andrei Racila 1
 
189.New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings
 

J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):98-103. doi: 10.1097/QAI.0000000000002517.

David Dunn 1 2, Huw Price 1, Tobias Vudriko 3, Cissy Kityo 4, Godfrey Musoro 5, James Hakim 5, Charles Gilks 6, Pontiano Kaleebu 3, Deenan Pillay 7, Richard Gilson 1, DART Virology Group
 
190.Distinct Hepatitis B and HIV co-infected populations in Canada
 

J Viral Hepat. 2020 Dec 11. doi: 10.1111/jvh.13453. Online ahead of print.

Curtis Cooper 1, Matt Driedger 1, David Wong 2, Sarah Haylock-Jacobs 3, Abdel Aziz Shaheen 3, Carla Osiowy 4, Scott Fung 2, Karen Doucette 5, Alexander Wong 6, Lisa Barrett 7, Brian Conway 8, Alnoor Ramji 9, Gerald Minuk, Giada Sebastiani, Philip Wong, Carla S Coffin 3
 
191.Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis
 

J Viral Hepat. 2020 Dec 10. doi: 10.1111/jvh.13452. Online ahead of print.

Cori Campbell 1, Tingyan Wang 1, Anna L McNaughton 1, Eleanor Barnes 1, Philippa C Matthews 1 2 3
 
192.Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data
 

Viruses. 2020 Nov 23;12(11):1344. doi: 10.3390/v12111344.

Stoyan Velkov 1, Ulrike Protzer 1 2, Thomas Michler 1 2
 
193.Host RNA quality control as a hepatitis B antiviral target
 

Antiviral Res. 2020 Nov 23;104972. doi: 10.1016/j.antiviral.2020.104972.Online ahead of print.

Timothy M Block 1, John A T Young 2, Hassan Javanbakht 3, Michael J Sofia 4, Tianlun Zhou 5
 
194.Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations
 

Vaccine. 2020 Nov 4;S0264-410X(20)31387-6. doi: 10.1016/j.vaccine.2020.10.067.Online ahead of print.

Elizabeth M Rosenthal 1, Eric W Hall 2, Eli S Rosenberg 3, Aaron Harris 4, Noele P Nelson 4, Sarah Schillie 4
 
195.Real world application of the Xpert® HBV Viral Load assay on serum and dried blood spots
 

J Med Virol. 2020 Nov 11. doi: 10.1002/jmv.26662. Online ahead of print.

Kathy Jackson 1, Rosemary Tekoaua 2, Xin Li 1, Stephen Locarnini 1
 
196.Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis
 

Drug Saf. 2020 Nov 3. doi: 10.1007/s40264-020-01014-2. Online ahead of print.

William R Treem 1, Melissa Palmer 2 3, Isabelle Lonjon-Domanec 4, Daniel Seekins 5, Lara Dimick-Santos 6, Mark I Avigan 6, John F Marcinak 7, Ajit Dash 8, Arie Regev 9, Eric Maller 10 11, Meenal Patwardhan 7, James H Lewis 12, Don C Rockey 13, Adrian M Di Bisceglie 14, James W Freston 15, Raul J Andrade 16, Naga Chalasani 17
 
197.Talking testing: Impact of a training intervention on midwives' antenatal HIV, hepatitis B and hepatitis C screening practice
 

Women Birth. 2020 Nov 3;S1871-5192(20)30358-9. doi: 10.1016/j.wombi.2020.10.001.Online ahead of print.

Jen Johnson 1, Caroline Carr 2, Susan J McDonald 3, Margaret M Flood 4
 
198.Hepatitis B Surface Antibody Titers and Hepatitis B Reactivation with Direct-Acting Antiviral Therapy for Hepatitis C
 

J Viral Hepat. 2020 Oct 12. doi: 10.1111/jvh.13421. Online ahead of print.

Shiva Poola 1, Sirish Sanaka 1, Kerry Sewell 2, Hans L Tillmann 1 3 4 5
 
199.We Are All Africans: A Highly Personal Migratory View of the History of Hepatitis B
 

Clin Liver Dis (Hoboken). 2020 Oct 7;16(Suppl 1):24-33. doi: 10.1002/cld.989.eCollection 2020 Oct.

Robert G Gish 1 2
 
200.Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West Virginia
 

Am J Prev Med. 2020 Oct 1;S0749-3797(20)30272-5. doi: 10.1016/j.amepre.2020.05.022.Online ahead of print.

Stacy Tressler 1, Christa Lilly 2, Diane Gross 3, Thomas Hulsey 4, Judith Feinberg 5
 
201.Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant
 

Ann Pharmacother. 2020 Sep 28;1060028020962050. doi: 10.1177/1060028020962050.Online ahead of print.

Caroline R Champion 1
 
202.Documentation of Hepatitis B Immunity in Nursing Students
 

Nurs Educ Perspect. 2020 Sep 22. doi: 10.1097/01.NEP.0000000000000736.Online ahead of print.

Julie Kientz Elting 1
 
203.Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes
 

Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa347. doi: 10.1093/ofid/ofaa347.eCollection 2020 Sep.

Zahid A Butt 1 2 3, Stanley Wong 2, Carmine Rossi 2, Mawuena Binka 2, Jason Wong 2 3, Amanda Yu 2, Maryam Darvishian 4, Maria Alvarez 2, Nuria Chapinal 4, Geoff Mckee 2, Mark Gilbert 2 3, Mark W Tyndall 3, Mel Krajden 2 3 5, Naveed Z Janjua 2 3
 
204.Low risk of hepatitis b reactivation in patients with severe COVID-19 who receive immunosuppressive therapy
 

J Viral Hepat. 2020 Sep 24. doi: 10.1111/jvh.13410. Online ahead of print.

Sergio Rodríguez-Tajes 1 2, Anna Miralpeix 1 2, Josep Costa 2 3, Ester López-Suñé 4, Montserrat Laguno 5, Anna Pocurull 1, Sabela Lens 1 2, Zoe Mariño 1 2, Xavier Forns 1 2
 
205.A global investment framework for the elimination of hepatitis B
 

J Hepatol. 2020 Sep 21;S0168-8278(20)33625-4. doi: 10.1016/j.jhep.2020.09.013.Online ahead of print.

Jessica Howell 1, Alisa Pedrana 2, Sophia E Schroeder 2, Nick Scott 2, Lisa Aufegger 3, Rifat Atun 4, Ricardo Baptista-Leite 5, Gottfried Hirnschal 6, Ellen 't Hoen 7, Sharon J Hutchinson 8, Jeffrey V Lazarus 9, Lesi Olufunmilayo 10, Raquel Peck 11, Manik Sharma 12, Annette H Sohn 13, Alexander Thompson 14, Mark Thursz 15, David Wilson 2, Margaret Hellard 16
 
206.Human Papillomavirus, Herpes Zoster, and Hepatitis B Vaccinations in Immunocompromised Patients: An Update for Pharmacists
 

J Pharm Pract. 2020 Sep 17;897190020958261. doi: 10.1177/0897190020958261.Online ahead of print.

Michelle R Paulsen 1, Nikitha R Patel 2, Carol Sulis 3, Francis A Farraye 4, Shubha Bhat 2
 
207.medLow Incidence of Adverse Outcomes in Adults with Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy
 

Hepatology. 2020 Sep 16.doi: 10.1002/hep.31554. Online ahead of print.

Anna S Lok 1, Robert Perrillo 2, Christina M Lalama 3, Michael W Fried 4, Steven H Belle 5, Marc G Ghany 6, Mandana Khalili 7, Robert J Fontana 1, Richard K Sterling 8, Norah Terrault 9, Jordan J Feld 10, Adrian M Di Bisceglie 11, Daryl T Y Lau 12, Mohamed Hassan 13, Harry L A Janssen 14, Hepatitis B Research Network (HBRN)

Collaborators

  • Hepatitis B Research Network (HBRN): 

Raymond T Chung, Lewis R Roberts, Mauricio Lisker-Melman, David K Wong, Joshua Juan, Colina Yim, Keyur Patel, William M Lee, Carol S Murakami, Son Do, Steven-Huy B Han, Tram T Tran, Stewart L Cooper, Naoky Tsai, Barak Younoszai, Andrew Muir, Donna Evon, Jama M Darling, Robert C Carithers, Kris V Kowdley, Chia C Wang, Velimir A Luketic, T Jake Liang, Jay H Hoofnagle, Edward Doo, Kyong-Mi Chang, Jang-June Park, Abdus Wahed, Wendy C King, David Kleiner
 
208.Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort Study
 

Open Forum Infect Dis. 2019 Nov 3;6(11):ofz469. doi: 10.1093/ofid/ofz469.eCollection 2019 Nov.

Jane Davies 1 2, Emma L Smith 2, Margaret Littlejohn 3, Rosalind Edwards 3, Vitina Sozzi 3, Kathy Jackson 3, Katie Mcguire 1, Paula Binks 1, Benjamin C Cowie 4 5, Stephen Locarnini 3, Joshua S Davis 1 6, Steven Y C Tong 1 7 8
 
209.Comparison of 48-week efficacy of tenofovir vs entecavir for patients with chronic hepatitis B: A network meta-analysis
 

J Viral Hepat. 2020 Sep 7. doi: 10.1111/jvh.13400. Online ahead of print.

Danny Con 1, Thomas Goodwin 2, Ammar Majeed 2 3, Stuart Roberts 2 3, William Kemp 2 3
 
210.HIV-, HBV-, and HCV-Related Information on U.S. Fertility Clinic Websites: A Content Analysis
 

Health Equity. 2020 Aug 14;4(1):345-352. doi: 10.1089/heq.2019.0100. eCollection 2020.

Margot Kelly-Hedrick 1, Marielle S Gross 2
 
211.Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants in community and faith settings using educational interventions - a prospective descriptive study
 

Int J Infect Dis. 2020 Aug 27;S1201-9712(20)30689-5. doi: 10.1016/j.ijid.2020.08.059.Online ahead of print.

Claire Kelly 1, Marinos Pericleous 1, Ayesha Ahmed 2, Tushna Vandrevala 3, Jane Hendy 2, Shuja Shafi 4, Simon Skene 5, Sumita Verma 6, Chantal Edge 7, Margot Nicholls 8, Charles Gore 9, Simon de Lusignan 10, Aftab Ala 11
 
212.Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis
 

Aliment Pharmacol Ther. 2020 Sep 4. doi: 10.1111/apt.16067. Online ahead of print.

Milan J Sonneveld 1, Willem P Brouwer 1, Bettina E Hansen 2, Henry L-Y Chan 3, Teerha Piratvisuth 4, Ji-Dong Jia 5, Stefan Zeuzem 6, Rong-Nan Chien 7, Hannah Choi 2, Robert J de Knegt 1, Cynthia Wat 8, Vedran Pavlovic 8, Anuj Gaggar 9, Qing Xie 10, Maria Buti 11, Robert A de Man 1, Harry L A Janssen 1 2, SONIC-B Study Group
 
213.Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection
 

Clin Infect Dis. 2020 Sep 1;ciaa1303. doi: 10.1093/cid/ciaa1303. Online ahead of print.

Mandana Khalili 1, Wendy C King 2, David E Kleiner 3, Mamta K Jain 4, Raymond T Chung 5, Mark Sulkowski 6, Mauricio Lisker-Melman 7, David K Wong 8, Marc Ghany 3, Arun Sanyal 9, Richard K Sterling 9, HIV-HBV Cohort Study of the Hepatitis B Research Network
 
214.Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS)
 

Transfusion. 2020 Aug 31. doi: 10.1111/trf.16005. Online ahead of print.

Whitney R Steele 1, Roger Y Dodd 1, Edward P Notari 1, Meng Xu 1, Diane Nelson 1, Debra A Kessler 2, Rita Reik 3, Alan E Williams 4, Brian Custer 5, Susan L Stramer 1, Transfusion-Transmissible Infections Monitoring System (TTIMS)
 
215.The Yin and the Yang of Treatment for Chronic Hepatitis B-When to Start, When to Stop Nucleos(t)ide Analogue Therapy
 

Viruses. 2020 Aug 25;12(9):E934. doi: 10.3390/v12090934.

Samuel Hall 1, Jessica Howell 1, Kumar Visvanathan 2, Alexander Thompson 1
 
216.The hepatitis B care cascade using administrative claims data, 2016
 

Am J Manag Care. 2020 Aug;26(8):331-338.doi: 10.37765/ajmc.2020.44069.

Aaron M Harris 1, Ademola Osinubi, Noele P Nelson, William W Thompson
 
217.Trends in Hepatitis B Surveillance Among Pregnant Women in New York City, 1998-2015
 

Public Health Re. 2020 Aug 14;33354920946793. doi: 10.1177/0033354920946793.Online ahead of print.

Robert J Arciuolo 1 2, Julie E Lazaroff 1, Jennifer B Rosen 1, Sungwoo Lim 3, Jane R Zucker 1 4
 
218.Susceptibility to Hepatitis A and B Virus Among Clients at a Syringe Services Program in Philadelphia, 2018
 

Public Health Rep. 2020 Aug 13;33354920943528. doi: 10.1177/0033354920943528.Online ahead of print.

Mary Figgatt 1, Jack Hildick-Smith 1, Eman Addish 1, Jennie Coleman 2, José Benitez 2, Catherine Freeland 3, Steven Alles 1, Kendra Viner 1, Caroline Johnson 1, Danica Kuncio 1
 
219.New blood borne virus infections among organ transplant recipients: an Australian data-linked cohort study examining donor-transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015
 

Transpl Infect Dis. 2020 Aug 7;e13437. doi: 10.1111/tid.13437. Online ahead of print.

Karen Mj Waller 1, Nicole L De La Mata 1, James A Hedley 1, Brenda M Rosales 1 2, Michael J O'Leary, Elena Cavazzoni 3, Vidiya Ramachandran 4, William D Rawlinson 4 5, Patrick J Kelly 1, Kate R Wyburn 2 6, Angela C Webster 1 7
 
220.Hepatitis A and B Vaccination in the United States
 

R I Med J (2013). 2020 Aug 3;103(6):44-46.

Martha C Sanchez 1
 
221.Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation
 

Hepatology. 2020 Aug 2. doi: 10.1002/hep.31491. Online ahead of print.

Elizabeth C Verna 1, Marina Serper 2, Jaime Chu 3, Kathleen Corey 4, Oren K Fix 5, Karen Hoyt 6, Kimberly A Page 7, Rohit Loomba 8, Ming Li 9, Gregory T Everson 10, Michael W Fried 11, Guadalupe Garcia-Tsao 12, Norah Terrault 9, Anna S Lok 13, Raymond T Chung 4, K Rajender Reddy 2
 
222.Hepatitis B Virus Mutant Infections in Hemodialysis Patients: A Case Series
 

Kidney Med. 2019 Oct 1;1(6):347-353. doi: 10.1016/j.xkme.2019.07.011.eCollection Nov-Dec 2019.

Ibironke W Apata 1 2, Duc B Nguyen 1, Yury Khudyakov 1, Tonya Mixson-Hayden 1, Jon Rosenberg 3, Matt Zahn 4, Jane Greenko 5, Ernest Clement 6, Allison E Portney 7 8, Prathit A Kulkarni 1 7, Maura Comer 9, Eleanor Adams 10, Saleem Kamili 1, Priti R Patel 1, Anne C Moorman 1
 
223.Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
 

Lancet Gastroenterol Hepatol. 2020 Jul 27;S2468-1253(20)30011-X.doi: 10.1016/S2468-1253(20)30011-X. Online ahead of print.

Adam Palayew 1, Homie Razavi 2, Sharon J Hutchinson 3, Graham S Cooke 4, Jeffrey V Lazarus 5
 
224.Progress towards elimination goals for viral hepatitis
 

Nat Rev Gastroenterol Hepatol. 2020 Jul 23;1-10. doi: 10.1038/s41575-020-0332-6.Online ahead of print.

Andrea L Cox 1, Manal H El-Sayed 2, Jia-Horng Kao 3 4, Jeffrey V Lazarus 5, Maud Lemoine 6, Anna S Lok 7, Fabien Zoulim 8 9 10
 
225.Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide
 

Dig Liver Dis. 2020 Jul 20;S1590-8658(20)30322-4. doi: 10.1016/j.dld.2020.06.037.Online ahead of print.

Luisa Roade 1, Alessandro Loglio 2, Marta Borghi 2, Mar Riveiro-Barciela 1, Roberta Soffredini 2, Floriana Facchetti 2, Dhanai di Paolo 2, David Tabernero 3, Giovanna Lunghi 4, Rafael Esteban 1, Maria Buti 5, Pietro Lampertico 6
 
226.A Predictive Model for Hepatitis B Infection Among High-Risk Adults Using a Community-Based Sample in Greater Philadelphia
 

J Viral Hepat. 2020 Jul 23. doi: 10.1111/jvh.13365. Online ahead of print.

Catherine Freeland 1, Daniel Vader 2, Chari Cohen 3, Brandon George 4
 
227.Circulating Pregenomic HBV RNA is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy
 

Clin Infect Dis. 2020 Jul 20;ciaa1015. doi: 10.1093/cid/ciaa1015. Online ahead of print.

Mark Anderson 1, Jeffery Gersch 1, Ka-Cheung Luk 1, George Dawson 1, Ivana Carey 2, Kosh Agarwal 3, Pir Shah 4, Geoffrey Dusheiko 3, Daryl Lau 5, Gavin Cloherty 1
 
228.Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategies
 

Mil Med. 2020 Jul 10;usaa131. doi: 10.1093/milmed/usaa131. Online ahead of print.

Paul T Scott 1, Robert L Cohen 2 3, David M Brett-Major 4, Shilpa Hakre 1 5, Jennifer A Malia 1, Jason F Okulicz 6, Charmagne G Beckett 7, Jason M Blaylock 8, Michael A Forgione 6, Stephen A Harrison 6, Clinton K Murray 6, Francisco J Rentas 9, Roland L Fahie 9, Adam W Armstrong 10, Aatif M Hayat 2, Laura A Pacha 2 11, Peter Dawson 12, Beth Blackwell 12, Angelia A Eick-Cost 13 14, Hala H Maktabi 13 15, Nelson L Michael 1, Linda L Jagodzinski 1, Steven B Cersovsky 2, Sheila A Peel 1
 
229.Immunity to Hepatitis B Is Undetectable in the Majority of Adolescents and Young Adults Seeking Outpatient Medication Treatment for Opioid Use Disorder
 

J Addict Med. 2020 Jun 12. doi: 10.1097/ADM.0000000000000689. Online ahead of print.

Samuel W Stull 1, Erin R McKnight, Steven C Matson, Andrea E Bonny
 
230.ATI-2173, A Novel Liver-Targeted Non-Chain Terminating Nucleotide for HBV Cure Regimens
 

Antimicrob Agents Chemother. 2020 Jun 15;AAC.00836-20. doi: 10.1128/AAC.00836-20.Online ahead of print.

Katherine E Squires 1, Douglas L Mayers 1, Gregory R Bluemling 2, Alexander A Kolykhalov 2, David B Guthrie 2, Prabhakar Reddy 2, Debbie G Mitchell 2, Manohar T Saindane 2, Zachary M Sticher 2, Vindhya Edpuganti 2, Abel De La Rosa 1
 
231.Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020
 

MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.

Jefferson M Jones, Ian Kracalik, Marilyn E Levi, James S Bowman 3rd, James J Berger, Danae Bixler, Kate Buchacz, Anne Moorman, John T Brooks, Sridhar V Basavaraju
 
232.Acute Hepatitis B Surge: Opioid Epidemic Implication and Management Challenges
 

Open Forum Infect Dis. 2020 May 23;7(6):ofaa190. doi: 10.1093/ofid/ofaa190.eCollection 2020 Jun.

Erik D Johansson 1, Marina Nunez 2
 
233.Evaluation of a Program to Improve Linkage to and Retention in Care Among Refugees With Hepatitis B Virus Infection - Three U.S. Cities, 2006-2018
 

MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):647-650doi: 10.15585/mmwr.mm6921a2.

Janine Young, Colleen Payton, Patricia Walker, Daniel White, Megan Brandeland, Gayathri S Kumar, Emily S Jentes, Ann Settgast, Malini DeSilva

Free PMC article
 
234.Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic HBV Infection: Systematic Review and Meta-analysis
 

Clin Gastroenterol Hepatol. 2020 May 27;S1542-3565(20)30748-5.doi: 10.1016/j.cgh.2020.05.041. Online ahead of print.

Ryan T Anderson 1, Hannah S J Choi 2, Oliver Lenz 3, Marion G Peters 4, Harry L A Janssen 5, Poonam Mishra 6, Eric Donaldson 7, Gabriel Westman 8, Stephanie Buchholz 9, Veronica Miller 10, Bettina E Hansen 11
 
235.Care Quality and Outcomes Among U.S. Veterans With Chronic Hepatitis B in the Hepatitis C Direct Acting Antiviral Era
 

Viral Hepat. 2020 Jun 2. doi: 10.1111/jvh.13340. Online ahead of print.

David E Kaplan 1 2, Elina Medvedeva 2, Marina Serper 1 3 2
 
236.Should Treatment Indications for Chronic Hepatitis B Be Expanded?
 

Clin Gastroenterol Hepatol. 2020 May 17;S1542-3565(20)30677-7.doi: 10.1016/j.cgh.2020.04.091. Online ahead of print.

Wen-Juei Jeng 1, Anna S Lok 2
 
237.A Best Practice Alert for Identifying Hepatitis B-Infected Patients
 

Am J Trop Med Hyg 2020 May 18.doi: 10.4269/ajtmh.20-0041. Online ahead of print.

Malini DeSilva 1 2, Amy Kodet 2, Patricia Walker 3 1 2
 
238.Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV
 

Vanwolleghem T1, Groothuismink ZMA2, Kreefft K2, Hung M3, Novikov N3, Boonstra A2. J Hepatol. 2020 Feb 12. pii: S0168-8278(20)30071-4. doi: 10.1016/j.jhep.2020.01.024. [Epub ahead of print]
 
239.Hepatitis B: Current Status of Therapy and Future Therapies
 

Gastroenterol Clin North Am. 2020 Jun;49(2):215-238.doi: 10.1016/j.gtc.2020.01.003. Epub 2020 Mar 29.

Elias Spyrou 1, Coleman I Smith 2, Marc G Ghany 3
 
240.Impact of a Vaccine Intervention on County-Level Rates of Acute Hepatitis B in West Virginia, 2011-2018
 

Prev Med. 2020 Aug;137:106121. doi: 10.1016/j.ypmed.2020.106121. Epub 2020 May 8.

Stacy R Tressler 1, Gordon S Smith 2, Brian M Hendricks 2
 
241.The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure
 

Viruses. 2020 May 7;12(5):E515.oi: 10.3390/v12050515.

Thomas Tu 1, Joan M Block 2, Su Wang 3 4, Chari Cohen 2, Mark W Douglas 1 5
 
242.Global Epidemiology of Viral Hepatitis
 

Gastroenterol Clin North Am. 2020 Jun;49(2):179-189.doi: 10.1016/j.gtc.2020.01.001.

Homie Razavi 1
 
243.Vitamin D and the Hepatitis B Vaccine Response: A Prospective Cohort Study and a Randomized, Placebo-Controlled Oral Vitamin D 3 and Simulated Sunlight Supplementation Trial in Healthy Adults
 

Nutr. 2020 May 10.doi: 10.1007/s00394-020-02261-w. Online ahead of print

Daniel S Kashi 1 2, Samuel J Oliver 3, Laurel M Wentz 4, Ross Roberts 1, Alexander T Carswell 1, Jonathan C Y Tang 5, Sarah Jackson 6, Rachel M Izard 7, Donald Allan 8, Lesley E Rhodes 9, William D Fraser 5, Julie P Greeves 5 6, Neil P Walsh 2
 
244.Adherence in Chronic Hepatitis B: Associations Between Medication Possession Ratio and Adverse Viral Outcomes
 

C Gastroenterol. 2020 May 7;20(1):140.doi: 10.1186/s12876-020-01219-w.

Nicole L Allard 1 2, Jennifer H MacLachlan 3 4, Anouk Dev 5, James Dwyer 6, Geeta Srivatsa 7, Timothy Spelman 4 8, Alexander J Thompson 4 9, Benjamin C Cowie 3 4
 
245.Prevalence and Clinical Features of Patients With Concurrent HBsAg and Anti-HBs: Evaluation of the Hepatitis B Research Network Cohort
 

J Viral Hepat. 2020 May 4.doi: 10.1111/jvh.13312. Online ahead of print.

William M Lee 1, Wendy C King 2, Kathleen B Schwarz 3, Jody Rule 1, Anna Sf Lok 4, HBRN Investigators
 
246.Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data
 

Clin Gastroenterol Hepatol. 2020 Apr 29;S1542-3565(20)30590-5.doi: 10.1016/j.cgh.2020.04.045. Online ahead of print.

Kyoko Yoshida 1, Alice Desbiolles 2, Sarah F Feldman 2, Sang Hoon Ahn 3, Enagnon K Alidjinou 4, Masanori Atsukawa 5, Laurence Bocket 4, Maurizia R Brunetto 6, Maria Buti 7, Ivana Carey 8, Gian Paolo Caviglia 9, En-Qiang Chen 10, Markus Cornberg 11, Masaru Enomoto 12, Masao Honda 13, Christoph Höner Zu Siederdissen 11, Masatoshi Ishigami 14, Harry LA Janssen 15, Benjamin Maasoumy 11, Takeshi Matsui 16, Akihiro Matsumoto 17, Shuhei Nishiguchi 18, Mar Riveiro-Barciela 7, Akinobu Takaki 19, Pisit Tangkijvanich 20, Hidenori Toyoda 21, Margo Jh van Campenhout 22, Bo Wang 8, Lai Wei 23, Hwai-I Yang 24, Yoshihiko Yano 25, Hiroshi Yatsuhashi 26, Man-Fung Yuen 27, Eiji Tanaka 28, Maud Lemoine 1, Yasuhito Tanaka 29, Yusuke Shimakawa 30
 
247.Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL
 

Clin Gastroenterol Hepatol. 2020 Apr 29;S1542-3565(20)30534-6.doi: 10.1016/j.cgh.2020.04.037. Online ahead of print.

Tzu-Ning Tseng 1, Tsung-Hui Hu 1, Jing-Houng Wang 1, Yuan-Hung Kuo 1, Chao-Hung Hung 2, Sheng-Nan Lu 2, Wen-Juei Jeng 3, Chien-Hung Chen 4
 
248.Improving Birth Dose Hepatitis B Vaccination Rates: A Quality Improvement Intervention
 

Hosp Pediatr. 2020 May;10(5):430-437. doi: 10.1542/hpeds.2019-0294.

Chanda Bradshaw 1, Eileen DiFrisco 2, William Schweizer 3, Joy Pavsic 4, Kathleen Demarco 4, Jane Weckesser 4, Gabrielle Gold-VonSimson 5, Rebecca E Rosenberg 5
 
249.Hepatitis B Surface Antigen Seroclearance: Immune Mechanisms, Clinical Impact, Importance for Drug Development
 

J Hepatol. 2020 Apr 22;S0168-8278(20)30225-7. doi: 10.1016/j.jhep.2020.04.013.Online ahead of print.

Issam Tout 1, Dimitri Loureiro 1, Abdellah Mansouri 1, Vassili Soumelis 2, Nathalie Boyer 1, Tarik Asselah 3
 
250.Hbsag Levels Can Be Used to Rule Out Cirrhosis in Hbeag Positive Chronic Hepatitis B: Results From the Sonic-B Study
 

J Infect Dis. 2020 Apr 21;jiaa192 doi: 10.1093/infdis/jiaa192. Online ahead of print.

Milan J Sonneveld 1, Bettina E Hansen 2 3, Willem P Brouwer 1, Henry L-Y Chan 4, Teerha Piratvisuth 5, Ji-Dong Jia 6, Stefan Zeuzem 7, R N Chien 8, R J de Knegt 1, Cynthia Wat 9, Vedran Pavlovic 9, Anuj Gaggar 10, Qing Xie 11, Maria Buti 12, R A de Man 1, Harry L A Janssen 1 2, SONIC-B Study group
 
251.Hepatitis B Virus Seroepidemiology Data for Africa: Modelling Intervention Strategies Based on a Systematic Review and Meta-Analysis
 

PLoS Med. 2020 Apr 21;17(4):e1003068. doi: 10.1371/journal.pmed.1003068.eCollection 2020 Apr.

Anna L McNaughton 1, José Lourenço 2, Phillip Armand Bester 3, Jolynne Mokaya 1, Sheila F Lumley 1 4, Uri Obolski 5 6, Donall Forde 7, Tongai G Maponga 8, Kenneth R Katumba 9, Dominique Goedhals 3, Sunetra Gupta 2, Janet Seeley 9 10, Robert Newton 9 11, Ponsiano Ocama 12, Philippa C Matthews 1 4
 
252.Comparative Effectiveness of Entecavir vs Tenofovir for Preventing Hepatocellular Carcinoma in Patients With Chronic Hepatitis B: A Systematic Review and Meta-analysis
 

Hepatology. 2020 Apr 10. doi: 10.1002/hep.31267. Online ahead of print.

Shravan Dave 1, Sooyoung Park 1 2, M Hassan Murad 3, Abbey Barnard 1, Larry Prokop 4, Leon A Adams 5, Siddharth Singh 1, Rohit Loomba 
 
253.Longitudinal Analysis of Serum MicroRNAs as Predictors of Cirrhosis Regression During Treatment of Hepatitis B Virus Infection
 

Liver Int. 2020 Apr 16. doi: 10.1111/liv.14474. Online ahead of print.

Cody Orr 1, Rob Myers 2, Biao Li 2, Zhaoshi Jiang 2, John Flaherty 2, Anuj Gaggar 2, Eric G Meissner 1
 
254.Final Analysis of the International Observational S-Collate Study of Peginterferon alfa-2a in Patients With Chronic Hepatitis B
 

PloS One. 2020 Apr 10;15(4):e0230893. doi: 10.1371/journal.pone.0230893. eCollection 2020.

Patrick Marcellin 1, Qing Xie 2, Seung Woon Paik 3, Robert Flisiak 4, Teerha Piratvisuth 5, Jörg Petersen 6, Tarik Asselah 1, Markus Cornberg 7, Denis Ouzan 8, Graham R Foster 9, Georgios Papatheodoridis 10, Diethelm Messinger 11, Loredana Regep 12, Georgios Bakalos 13, Ulrich Alshuth 14, Pietro Lampertico 15, Heiner Wedemeyer 7
 
255.Statin and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis
 

BMC Gastroenterol. 2020 Apr 9;20(1):98.doi: 10.1186/s12876-020-01222-1.

Xiaofei Li 1, Lina Sheng 2, Liwen Liu 2, Yongtao Hu 2, Yongxin Chen 2, Lianqing Lou 2
 
256.Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States
 

 JAMANetw Open. 2020 Apr 1;3(4):e201844. doi: 10.1001/jamanetworkopen.2020.1844.

Eiichi Ogawa 1 2, Yee Hui Yeo 1, Nolan Dang 1, Michael H Le 1, Donghak Jeong 1, Sally Tran 1, Linda Henry 1, Ramsey Cheung 1 3, Mindie H Nguyen 1
 
257.Preferences of Patients with Chronic Hepatitis B - A Discrete Choice Experiment on the Acceptability of Functional Cure
 

Hardtstock F#1, Sbarigia U#2, Kocaata Z1, Wilke T1, Sylvester SV3. Patient Prefer Adherence. 2020 Mar 19;14:613-624. doi: 10.2147/PPA.S238833. eCollection 2020.
 
258.Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada
 

Rodriguez-Baez N1, Murray KF2, Kleiner DE3, Ling SC4, Rosenthal P5, Carlin K6, Cooper K6, Schwarz KB7, Schwarzenberg SJ8, Teckman JH9, Ghany MG10, Alawad A10. J Pediatr Gastroenterol Nutr. 2020 Apr 3. doi: 10.1097/MPG.0000000000002712. [Epub ahead of print]
 
259.Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey
 

Mukhtar NA1, Evon DM2, Yim C3, Lok AS4, Lisha N5, Lisker-Melman M6, Hassan M7, Janssen HLA3, Khalili M8. Dig Dis Sci. 2020 Apr 1. doi: 10.1007/s10620-020-06224-3. [Epub ahead of print]
 
260.Chronic Hepatitis B infection and the risk of gestational diabetes: a cross sectional study
 

Giles M1,2, Davey MA1, Wallace E1. BJOG. 2020 Mar 16. doi: 10.1111/1471-0528.16217. [Epub ahead of print]
 
261.Present and future management of viral hepatitis B and C in children
 

Clemente MG1, Antonucci R2, Sotgiu G2, Dettori M2, Piana A2, Vajro P3. Clin Res Hepatol Gastroenterol. 2020 Mar 12. pii: S2210-7401(20)30043-7. doi: 10.1016/j.clinre.2020.02.010. [Epub ahead of print]
 
262.Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B
 

Hadziyannis E1, Hadziyannis S1. Expert Rev Gastroenterol Hepatol. 2020 Apr;14(4):243-251. doi: 10.1080/17474124.2020.1738219. Epub 2020 Mar 12.
 
263.Hepatitis B prophylaxis in adolescents who present for examination after alleged sexual assault
 

Jones ME1,2,3, Tully JM1,2,3. J Paediatr Child Health. 2020 Mar 12. doi: 10.1111/jpc.14860. [Epub ahead of print]
 
264.Universal Screening and Vaccination for Hepatitis B in Pregnancy: The Time Is Now
 

Prabhu M1, Riley LE. Obstet Gynecol. 2020 Apr;135(4):808-811. doi: 10.1097/AOG.0000000000003706.
 
265.Barriers to Hepatitis B Screening and Prevention for African Immigrant Populations in the United States: A Qualitative Study
 

Freeland C1, Bodor S1, Perera U2, Cohen C1. Viruses. 2020 Mar 11;12(3). pii: E305. doi: 10.3390/v12030305.
 
266.Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
 

Chan TT1, Chan WK2, Wong GL1,3, Chan AW4, Nik Mustapha NR5, Chan SL6, Chong CC7, Mahadeva S2, Shu SS1,3, Lai PB7, Chan HL1,3, Wong VW1,3. Am J Gastroenterol. 2020 Mar 9. doi: 10.14309/ajg.0000000000000588. [Epub ahead of print]
 
267.A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B
 

Chen Y1,2, Cao D2, Li C1,2, Zhang P1,2, Wang X1, Li N1, Han Q1, Liu Z1. Eur J Gastroenterol Hepatol. 2020 Feb 27. doi: 10.1097/MEG.0000000000001691. [Epub ahead of print]
 
268.Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America
 

Brahmania M1, Liu S2, Wahed AS3, Yim C1, Hansen BE4, Khalili M5, Terrault NA5, Lok AS6, Ghany M7, Wang J2, Wong D1, Janssen HLA8; Hepatitis B Research Network. Ann Hepatol. 2020 Feb 8. pii: S1665-2681(20)30009-0. doi: 10.1016/j.aohep.2020.01.005. [Epub ahead of print]
 
269.No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic HBV Infection Treated With Entecavir vs Tenofovir
 

Oh H1, Yoon EL2, Jun DW3, Ahn SB4, Lee HY4, Jeong JY5, Kim HS6, Jeong SW7, Kim SE8, Shim JJ9, Sohn JH10, Cho YK11; Long-term Safety of Entecavir and Tenofovir in Patients with Treatment-naive Chronic Hepatitis B virus (CHB) Infection (SAINT) study. Clin Gastroenterol Hepatol. 2020 Mar 2. pii: S1542-3565(20)30265-2. doi: 10.1016/j.cgh.2020.02.046. [Epub ahead of print]
 
270.Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis
 

Harigai M1, Winthrop K2, Takeuchi T3, Hsieh TY4, Chen YM4, Smolen JS5, Burmester G6, Walls C7, Wu WS7, Dickson C7, Liao R7, Genovese MC8. RMD Open. 2020 Feb;6(1). pii: e001095. doi: 10.1136/rmdopen-2019-001095
 
271.Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis
 

Gao X1,2, Yang HI3, Trinh H4, Jeong D1, Li J5, Zhang J6, Le A1, Hoang J1, Nguyen P1, Henry L1, Nguyen MH1. Eur J Gastroenterol Hepatol. 2019 Dec 24. doi: 10.1097/MEG.0000000000001639.

 
272.Hepatitis B: Who to treat? A critical review of international guidelines
 

Huang DQ1,2, Lim SG1,2. Liver Int. 2020 Feb;40 Suppl 1:5-14. doi: 10.1111/liv.14365.
 
273.Approach to the patient with chronic hepatitis B and decompensated cirrhosis
 

Shiffman ML1. Liver Int. 2020 Feb;40 Suppl 1:22-26. doi: 10.1111/liv.14359.
 
274.Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data
 

Philip G1, Djerboua M2, Carlone D3, Flemming JA1,2,3,4. PLoS One. 2020 Feb 18;15(2):e0229218. doi: 10.1371/journal.pone.0229218. eCollection 2020.
 
275.Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data
 

Philip G1, Djerboua M2, Carlone D3, Flemming JA1,2,3,4. PLoS One. 2020 Feb 18;15(2):e0229218. doi: 10.1371/journal.pone.0229218. eCollection 2020.
 
276.Will we need novel combinations to cure HBV infection?
 

Dusheiko G1,2. Liver Int. 2020 Feb;40 Suppl 1:35-42. doi: 10.1111/liv.14371.
 
277.Management of hepatitis B in the era of checkpoint inhibition
 

Dutcher J1. J Immunother Cancer. 2020 Feb;8(1). pii: e000276. doi: 10.1136/jitc-2019-000276.
 
278.'Think Hep B' in primary care: A before-and-after evaluation of a self-guided learning package
 

Xiao Y1, van Gemert C2, Howell J3, Adamson E4, Towell V5, Cowie BC6, Thompson AJ7, Hellard M8. Aust J Gen Pract. 2020 Jan-Feb;49(1-2):66-69. doi: 10.31128/AJGP-10-18-4739.
 
279.Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
 

Joshi SS1,2, Coffin CS1,2. Hepatol Commun. 2020 Jan 2;4(2):157-171. doi: 10.1002/hep4.1460. eCollection 2020 Feb.
 
280.Comparing the Effects of Different Story Types and Speakers in Hepatitis B Storytelling Videos
 

Alber JM1, Cohen C2, Bleakley A3, Ghazvini SF1, Tolentino BT1, Almeida R1, Chance BL1. Health Promot Pract. 2020 Jan 19:1524839919894248. doi: 10.1177/1524839919894248. [Epub ahead of print]
 
281.Evaluating North Carolina's policy for healthcare personnel living with HIV and hepatitis B who perform invasive procedures after 25 years of implementation
 

Mitchell CL1, Lewis JW1,2, Maillard JM2, Moore ZS2, Weber DJ1. Infect Control Hosp Epidemiol. 2020 Jan 27:1-3. doi: 10.1017/ice.2019.372. [Epub ahead of print]
 
282.Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study
 

Gao R1, Gabr A1, Mouli S1, Riaz A1, Kulik L2, Lewandowski RJ1, Salem R3. J Vasc Interv Radiol. 2020 Jan 23. pii: S1051-0443(19)30808-5. doi: 10.1016/j.jvir.2019.08.033. [Epub ahead of print]
 
283.Hepatitis C virologic response in Hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES
 

Butt AA1, Yan P2, Aslam S2, Sherman KE3, Siraj D4, Safdar N4, Hameed B5. Int J Infect Dis. 2020 Jan 21. pii: S1201-9712(20)30027-8. doi: 10.1016/j.ijid.2020.01.025. [Epub ahead of print]
 
284.Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis
 

Evon DM1, Lin HS2, Khalili M3, Fontana RJ4, Yim C5, Wahed AS2, Fried MW1, Hoofnagle JH6; Hepatitis B Research Network (HBRN). Aliment Pharmacol Ther. 2020 Feb;51(4):457-468. doi: 10.1111/apt.15618. Epub 2020 Jan 14.
 
285.Direct comparison of three residual risk models for hepatitis B virus window period infections using updated input parameters
 

Lelie N1, Vermeulen M2, van Drimmelen H3, Coleman C2, Bruhn R4, Reddy R2, Busch M4, Kleinman S5. Vox Sang. 2020 Jan 20. doi: 10.1111/vox.12889. [Epub ahead of print]
 
286.Cross-sectional study of hepatitis B antibody status in health care workers immunized as children at an academic medical center in Wisconsin
 

Ritscher AM1, LeClair-Netzel M2, Friedlander NJ3, Howard Stewart DN1, Wagner M4, Kalscheur N5, Caldera F6, Hayney MS7. Vaccine. 2020 Jan 16. pii: S0264-410X(19)31678-0. doi: 10.1016/j.vaccine.2019.12.036. [Epub ahead of print]
 
287.Within-host mathematical models of hepatitis B virus infection: Past, present, and future
 

Goyal A1, Liao LE1, Perelson AS1. Curr Opin Syst Biol. 2019 Dec;18:27-35. doi: 10.1016/j.coisb.2019.10.003. Epub 2019 Nov 2.
 
288.Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
 

de Martel C1, Georges D2, Bray F3, Ferlay J3, Clifford GM2. Lancet Glob Health. 2019 Dec 17. pii: S2214-109X(19)30488-7. doi: 10.1016/S2214-109X(19)30488-7. [Epub ahead of print]
 
289.Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
 

Lok AS1, Zoulim F2, Dusheiko G3, Chan HLY4, Buti M5, Ghany MG6, Gaggar A7, Yang JC7, Wu G7, Flaherty JF7, Subramanian GM7, Locarnini S8, Marcellin P9. Hepatol Commun. 2019 Oct 10;4(1):8-20. doi: 10.1002/hep4.1436. eCollection 2020 Jan.
 
290.Hepatitis B virus RNA as Early Predictor for Response to PEGylated Interferon Alfa in HBeAg Negative Chronic Hepatitis B
 

Farag MS1,2, van Campenhout MJH3, Pfefferkorn M4, Fischer J4, Deichsel D4, Boonstra A3, van Vuuren AJ3, Ferenci P5, Feld JJ1, Berg T4, Hansen BE1,6, van Bömmel F4, Janssen HLA1. Clin Infect Dis. 2020 Jan 8. pii: ciaa013. doi: 10.1093/cid/ciaa013. [Epub ahead of print]
 
291.Hepatitis B virus activity is not associated with degree of liver steatosis in patients with hepatitis B-related chronic liver disease
 

Worland T1, Apostolov R1, Asadi K1, Leung C1. Liver Int. 2019 Dec 28. doi: 10.1111/liv.14344. [Epub ahead of print]
 
292.Interventions to Increase Completion of Hepatitis B Vaccination in People who Inject Drugs: A Systematic Review and Meta-analysis
 

Tressler S1, Bhandari R1. Open Forum Infect Dis. 2019 Dec 6;6(12):ofz521. doi: 10.1093/ofid/ofz521. eCollection 2019 Dec.
 
293.Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis
 

Li M1, Lv T2, Wu S1, Wei W1, Wu X3, Ou X2, Ma H2, Chow SC4, Kong Y5, You H6, Jia J7. Hepatol Int. 2020 Jan 3. doi: 10.1007/s12072-019-10005-0. [Epub ahead of print]
 
294.Enhancing the hepatitis B care cascade in Australia: A cost-effectiveness model
 

Xiao Y1,2,3, Howell J1,2,3,4, van Gemert C1,3, Thompson AJ2,3, Seaman CP1,4, McCulloch K3,5,6,7, Scott N1,4, Hellard ME1,3,4,7,8,9. J Viral Hepat. 2019 Dec 19. doi: 10.1111/jvh.13252. [Epub ahead of print]
 
295.Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
 

Sarin SK1, Kumar M2, Eslam M3, George J3, Al Mahtab M4, Akbar SMF5, Jia J6, Tian Q6, Aggarwal R7, Muljono DH8, Omata M9, Ooka Y10, Han KH11, Lee HW11, Jafri W12, Butt AS12, Chong CH13, Lim SG14, Pwu RF15, Chen DS16. Lancet Gastroenterol Hepatol. 2019 Dec 13. pii: S2468-1253(19)30342-5. doi: 10.1016/S2468-1253(19)30342-5. [Epub ahead of print]
 
296.Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES
 

Butt AA1,2,3, Yan P1, Aslam S1, Abou-Samra AB2,3, Sherman KE4, Shaikh OS1. Clin Infect Dis. 2019 Dec 16. pii: ciz1097. doi: 10.1093/cid/ciz1097. [Epub ahead of print]
 
297.Review article: clinical pharmacology of current and investigational hepatitis B virus therapies
 

Smolders EJ1,2,3, Burger DM3, Feld JJ4, Kiser JJ1. Aliment Pharmacol Ther. 2020 Jan;51(2):231-243. doi: 10.1111/apt.15581. Epub 2019 Dec 16.
 
298.Role of Biomarkers in Guiding Cure of Viral Hepatitis B
 

Buti M1,2, Riveiro-Barciela M1,2, Rodríguez-Frías F2,3,4, Tabernero D2,3, Esteban R1,2. Semin Liver Dis. 2019 Dec 5. doi: 10.1055/s-0039-3401031. [Epub ahead of print]
 
299.Role of Biomarkers in Guiding Cure of Viral Hepatitis B
 

Buti M1,2, Riveiro-Barciela M1,2, Rodríguez-Frías F2,3,4, Tabernero D2,3, Esteban R1,2. Semin Liver Dis. 2019 Dec 5. doi: 10.1055/s-0039-3401031. [Epub ahead of print]
 
300.Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers
 

Mahfouz M1, Nguyen H2, Tu J3, Diaz CR4,5, Anjan S6, Brown S4, Bosire K7, Carrasquillo O4,8, Martin P8,9, Jones PD10,11. Dig Dis Sci. 2019 Dec 7. doi: 10.1007/s10620-019-05980-1. [Epub ahead of print]
 
301.Liver safety assessment in clinical trials of new agents for chronic hepatitis B
 

Fontana RJ1, Avigan MI2, Janssen HLA3, Regev A4, Mishra P5, Gaggar A6, Brown N7, Wat C8, Mendez P9, Anderson RT10, Given B11, Miller V10, Beumont M12. J Viral Hepat. 2019 Dec 11. doi: 10.1111/jvh.13223. [Epub ahead of print]
 
302.Quantification of Hepatitis B Surface Antigen: Is there a Role in HIV-Hepatitis B Virus Coinfection?
 

Jakharia N1, Kottilil S1, Chua JV1. AIDS Rev. 2019;21(4):175-183. doi: 10.24875/AIDSRev.19000077.
 
303.Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study
 

Abreu RM1,2, Bassit LC3, Tao S3, Jiang Y3, Ferreira AS1, Hori PC2, Ganova-Raeva LM4, Khudyakov Y4, Schinazi RF3, Carrilho FJ1, Ono SK1. Antivir Ther. 2019 Dec 4. doi: 10.3851/IMP3338. [Epub ahead of print]
 
304.Incidence and Risk Factors of Postoperative Mortality and Morbidity After Elective Versus Emergent Abdominal Surgery in a National Sample of 8193 Patients With Cirrhosis
 

Johnson KM1,2, Newman KL3, Green PK4, Berry K4, Cornia PB1,2, Wu P5, Beste LA4,6,2, Itani K7, Harris AHS8,9, Kamath PS10, Ioannou GN4,11. Ann Surg. 2019 Oct 23. doi: 10.1097/SLA.0000000000003674. [Epub ahead of print]
 
305.Quantitative of serum hepatitis B core antibody is a potential predictor of recurrence after interferon-induced hepatitis B surface antigen clearance
 

Wu Y1, Wang X1, Lin X1, Shen C2, Chen X3. J Microbiol Immunol Infect. 2019 Sep 28. pii: S1684-1182(19)30145-8. doi: 10.1016/j.jmii.2019.09.004. [Epub ahead of print]
 
306.Point of care and oral fluid Hepatitis B testing in remote Indigenous communities of northern Australia
 

Sullivan RP1,2,3, Davies J1,2, Binks P1, Dhurrkay RG1, Gurruwiwi GG1, Bukulatjpi SM1, McKinnon M1, Hosking K1,4, Littlejohn M5, Jackson K5, Locarnini S5, Davis JS1,6, Tong SY1,7. J Viral Hepat. 2019 Nov 29. doi: 10.1111/jvh.13243. [Epub ahead of print]
 
307.Asian Consensus Recommendations on Optimizing the Diagnosis and Initiation of Treatment of Hepatitis B Virus Infection in Resource-Limited Settings
 

Gane EJ1, Charlton MR2, Mohamed R3, Sollano JD4, Tun KS5, Thuy PTT6, Payawal DA7, Gani RA8, Muljono DH9,10,11, Acharya SK12, Zhuang H13, Shukla A14, Madan K15, Saraf N16, Tyagi S17, Singh KR18, Cua IHY19, Jargalsaikhan G20,21, Duger D22, Sukeepaisarnjaroen W23, Purnomo HD24, Hasan I25, Lesmana LA26, Lesmana CRA27, Kyi KP28, Naing W29, Ac R30, Hadigal S30. J Viral Hepat. 2019 Nov 30. doi: 10.1111/jvh.13244. [Epub ahead of print]
 
308.Emerging tools in the changing landscape of chronic hepatitis B management
 

Gill US1, Battisti A1, Kennedy PT1. Expert Rev Anti Infect Ther. 2019 Nov 18. doi: 10.1080/14787210.2019.1694906. [Epub ahead of print]
 
309.Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
 

Cornberg M1,2,3, Lok AS4, Terrault NA5, Zoulim F6; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Hepatology. 2019 Nov 12. doi: 10.1002/hep.31030. [Epub ahead of print]
 
310.Hepatitis Flare In Hepatitis B Core Antibody Positive Kidney Recipients Treated With Rituximab
 

Raja M1, Natori Y1, Donato C1, De Lima D2, Centino A3, Mattiazzi A4, Morris M1. Transpl Infect Dis. 2019 Nov 12:e13211. doi: 10.1111/tid.13211. [Epub ahead of print]
 
311.Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
 

Cornberg M1, Suk-Fong Lok A2, Terrault NA3, Zoulim F4; 2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. J Hepatol. 2019 Nov 9. pii: S0168-8278(19)30671-3. doi: 10.1016/j.jhep.2019.11.003. [Epub ahead of print]
 
312.RNA Interference Therapy with ARC-520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection
 

Yuen MF1, Schiefke I2, Yoon JH3, Ahn SH4, Heo J5, Kim JH6, Chan HLY7, Yoon KT8, Klinker H9, Manns M10, Petersen J11, Schluep T12, Hamilton J12, Given BD12, Ferrari C13, Lai CL1, Locarnini SA14, Gish RG15. Hepatology. 2019 Oct 26. doi: 10.1002/hep.31008. [Epub ahead of print]
 
313.Occult HBV Infection: A Case Series at a Military Treatment Facility
 

Pak K1, Ordway S2, Torres D2. Mil Med. 2019 Nov 4. pii: usz379. doi: 10.1093/milmed/usz379. [Epub ahead of print]
 
314.A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations
 

Wong RJ1, Khalili M2. J Clin Gastroenterol. 2019 Oct 31. doi: 10.1097/MCG.0000000000001276. [Epub ahead of print]
 
315.'Teach-back' is a simple communication tool that improves disease knowledge in people with chronic hepatitis B - a pilot randomized controlled study
 

Tran S1,2, Bennett G3,4, Richmond J3,4,5, Nguyen T3,4, Ryan M3,4, Hong T3,4, Howell J3,4, Demediuk B3,4, Desmond P3,4, Bell S3,4, Thompson A6,7. BMC Public Health. 2019 Oct 23;19(1):1355. doi: 10.1186/s12889-019-7658-4.
 
316. Surveillance-Based Estimate of the Prevalence of Chronic Hepatitis B Virus Infection, New York City, 2016.
 

Moore MS1, Bocour A1, Winters A1. Public Health Rep. 2019 Oct 24:33354919882962. doi: 10.1177/0033354919882962. [Epub ahead of print]
 
317.Long-term Outcomes with Oral Therapy in Liver Transplant Recipients with Hepatitis B
 

Saab S1,2,3, Song D2, Challita YP1, Zhou TX1, Saab EG1, Viramontes MR1, Choi G1,2, Durazo FA1,2, Han SB1,2, El Kabany MM1,2, Jackson NJ4, Busuttil RW1. Clin Transplant. 2019 Oct 25:e13740. doi: 10.1111/ctr.13740. [Epub ahead of print]
 
318.National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018
 

Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S. MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718-723. doi: 10.15585/mmwr.mm6833a2.
 
319.Factors Associated with Hepatitis B Exposure among People who Report Using Methamphetamine: NHANES 2009-2016
 

Tressler SR1, Kushner T2, Bhandari R1. J Infect Dis. 2019 Aug 30. pii: jiz445. doi: 10.1093/infdis/jiz445. [Epub ahead of print]
 
320.HIV and the liver
 

Sherman KE1, Peters MG2, Thomas DL3. Top Antivir Med. 2019 Sep/Oct;27(3):101-110.
 
321.Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis
 

Platt L1, French CE2, McGowan CR1,3, Sabin K4, Gower E5, Trickey A2, McDonald B6,7, Ong J7, Stone J2, Easterbrook P8, Vickerman P2. J Viral Hepat. 2019 Oct 11. doi: 10.1111/jvh.13217. [Epub ahead of print]
 
322.The role of iron in viral infections
 

Schmidt SM1. Front Biosci (Landmark Ed). 2020 Jan 1;25:893-911.
 
323.Hepatitis B virus reactivation: Risk factors and current management strategies
 

Smalls DJ1, Kiger RE1, Norris LB1,2, Bennett CL1,2,3,4,5, Love BL1,2,3. Pharmacotherapy. 2019 Oct 9. doi: 10.1002/phar.2340. [Epub ahead of print]
 
324.Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation
 

Krueger KM1, Ison MG2, Ghossein C3. Am J Kidney Dis. 2019 Oct 1. pii: S0272-6386(19)30891-1. doi: 10.1053/j.ajkd.2019.06.014. [Epub ahead of print]
 
325.Trends in Hepatitis B Infection and Immunity among Women of Childbearing Age in the United States
 

Kushner T1, Chen Z2, Tressler S3, Kaufman H2, Feinberg J4, Terrault NA5. Clin Infect Dis. 2019 Aug 26. pii: ciz841. doi: 10.1093/cid/ciz841. [Epub ahead of print]
 
326.Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection
 

Koepke R1,2, Sill DN1, Akhtar WZ2, Mitchell KP1, Guilfoyle SM1, Westergaard RP2, Schauer SL1, Vergeront JM1. Public Health Rep. 2019 Sep 20:33354919874088. doi: 10.1177/0033354919874088. [Epub ahead of print]
 
327.Factors Associated with Hepatitis B Exposure among People who Report Using Methamphetamine: NHANES 2009-2016
 

Tressler SR1, Kushner T2, Bhandari R1. J Infect Dis. 2019 Aug 30. pii: jiz445. doi: 10.1093/infdis/jiz445. [Epub ahead of print]
 
328.Insight into hepatitis B prevalence and risk factors among Vietnamese Americans: a cross-sectional analysis of data from a community-based screening program
 

Lee AW1, Jacobs W2, Chan E3, Nguyen B4, Hua DN4, Ho JN4, Yuen P3, Van Nguyen T4. BMJ Open. 2019 Aug 26;9(8):e029616. doi: 10.1136/bmjopen-2019-029616.
 
329.Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort
 

Schwarz KB1, Lombardero M2, Di Bisceglie AM3, Murray KF4, Rosenthal P5, Ling SC6, Cloonan YK2, Rodriguez-Baez N7, Schwarzenberg SJ8, Hoofnagle JH9, Teckman J3; Hepatitis B Research Network (HBRN). J Pediatr Gastroenterol Nutr. 2019 Aug 20. doi: 10.1097/MPG.0000000000002467. [Epub ahead of print]
 
330.Current perspectives into the evaluation and management of hepatitis B: a review
 

Manne V1, Gochanour E1, Kowdley KV1. Hepatobiliary Surg Nutr. 2019 Aug;8(4):361-369. doi: 10.21037/hbsn.2019.02.09.
 
331.Twitter As a Noninvasive Bio-Marker for Trends in Liver Disease
 

Da BL1, Surana P2, Schueler SA1, Jalaly NY2, Kamal N1, Taneja S1, Vittal A2, Gilman CL2, Heller T2, Koh C2. Hepatol Commun. 2019 Jul 13;3(9):1271-1280. doi: 10.1002/hep4.1394. eCollection 2019 Sep.
 
332.Infectious disease screening in patients prior to undergoing immunosuppressive therapy
 

Sullivan R1,2, Gaskell C3, R Lewis C4,5, Vollmer-Conna U6, Post JJ1,4. Int J Clin Pract. 2019 Aug 23. doi: 10.1111/ijcp.13406. [Epub ahead of print]
 
333.Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV
 

Farooq PD1, Sherman KE2. Curr HIV/AIDS Rep. 2019 Aug 29. doi: 10.1007/s11904-019-00461-6. [Epub ahead of print]
 
334.Hepatitis B virus infection as a risk factor for chronic kidney disease.
 

Fabrizi F1, Cerutti R1, Ridruejo E2,3,4. Expert Rev Clin Pharmacol. 2019 Sep;12(9):867-874. doi: 10.1080/17512433.2019.1657828. Epub 2019 Aug 28.
 
335.Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV
 

Farooq PD1, Sherman KE2. Curr HIV/AIDS Rep. 2019 Aug 29. doi: 10.1007/s11904-019-00461-6. [Epub ahead of print]
 
336.Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort
 

Schwarz KB1, Lombardero M2, Di Bisceglie AM3, Murray KF4, Rosenthal P5, Ling SC6, Cloonan YK2, Rodriguez-Baez N7, Schwarzenberg SJ8, Hoofnagle JH9, Teckman J3; Hepatitis B Research Network (HBRN). J Pediatr Gastroenterol Nutr. 2019 Aug 20. doi: 10.1097/MPG.0000000000002467. [Epub ahead of print]
 
337.Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review
 

Wigfield P1, Sbarigia U2, Hashim M3, Vincken T3, Heeg B3. Pharmacoecon Open. 2019 Aug 19. doi: 10.1007/s41669-019-00175-w. [Epub ahead of print]
 
338.The effects of message framing and healthcare provider recommendation on adult hepatitis Bvaccination: A randomized controlled trial
 

Kasting ML1, Head KJ2, Cox D3, Cox AD4, Zimet GD5. Prev Med. 2019 Aug 9:105798. doi: 10.1016/j.ypmed.2019.105798. [Epub ahead of print]
 
339.Screening for Hepatitis B Virus Infection in Pregnant Women: An Updated Systematic Review for the U.S. Preventive Services Task Force
 

Henderson JT, Webber EM, Bean SI. 
 
340.Modelling progress towards elimination of hepatitis B in Australia
 

McCulloch K1,2, Romero N1,3, MacLachlan J1,3, Allard N1,3, Cowie B1,3,4. Hepatology. 2019 Aug 16. doi: 10.1002/hep.30899. [Epub ahead of print]
 
341.Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up
 

Joshi SS1,2, Gao S1,2, Castillo E3, Coffin CS4,5. Dig Dis Sci. 2019 Aug 2. doi: 10.1007/s10620-019-05745-w. [Epub ahead of print]
 
342.Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
 

Sagnelli C1, Pisaturo M2, Calò F2, Martini S2, Sagnelli E2, Coppola N2. World J Gastroenterol. 2019 Jul 14;25(26):3299-3312. doi: 10.3748/wjg.v25.i26.3299.
 
343.Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: a biomarker for functional cure
 

Walsh R1, Hammond R1, Yuen L1, Deerain J1, O'Donnell T1, Leary T2, Cloherty G2, Gaggar A3, Kitrinos K3, Subramanian M3, Wong D4, Locarnini S1.

Liver Int. 2019 Aug 4. doi: 10.1111/liv.14207. [Epub ahead of print]
 
344.Prevalence of Hepatitis B Virus Exposure in the Veterans Health Administration and Association With Military-related Risk Factors
 

Beste LA1, Ioannou GN2, Chang MF3, Forsberg CW4, Korpak AM4, Boyko EJ5, Sporleder JL6, Smith NL7, Maynard C8, Chartier M9, Dominitz JA10; VA Cooperative Study Group #488. Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30845-6. doi: 10.1016/j.cgh.2019.07.056. [Epub ahead of print]
 
345.Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review
 

Mason LM1, Duffell E2, Veldhuijzen IK3, Petriti U1, Bunge EM1, Tavoschi L4,2. Euro Surveill. 2019 Jul;24(30). doi: 10.2807/1560-7917.ES.2019.24.30.1800614.
 
346.Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects
 

Lombardi A1,2, Mondelli MU1,2. Aliment Pharmacol Ther. 2019 Aug 4. doi: 10.1111/apt.15449. [Epub ahead of print]
 
347.Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy
 

Fan R1, Zhou B1, Xu M2, Tan D3, Niu J4, Wang H5, Ren H6, Chen X7, Wang M8, Ning Q9, Shi G10, Sheng J11, Tang H12, Bai X13, Liu S1, Lu F14, Peng J1, Sun J15, Xie Q16, Hou J17; Chronic Hepatitis B Study Consortium.Collaborators (9) Clin Gastroenterol Hepatol. 2019 Jul 27. pii: S1542-3565(19)30790-6. doi: 10.1016/j.cgh.2019.07.046. [Epub ahead of print]
 
348.Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: a systematic review
 

Mason LMK1, Veldhuijzen IK2, Duffell E3, van Ahee A1, Bunge EM1, Amato-Gauci AJ3, Tavoschi L3. J Viral Hepat. 2019 Jul 22. doi: 10.1111/jvh.13182. [Epub ahead of print]
 
349.Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement
 

US Preventive Services Task Force, Owens DK1,2, Davidson KW3, Krist AH4,5, Barry MJ6, Cabana M7, Caughey AB8, Doubeni CA9, Epling JW Jr10, Kemper AR11, Kubik M12, Landefeld CS13, Mangione CM14, Pbert L15, Silverstein M16, Simon MA17, Tseng CW18,19, Wong JB20. JAMA. 2019 Jul 23;322(4):349-354. doi: 10.1001/jama.2019.9365.
 
350.Evaluation of Rapid Diagnostic Tests for Assessment of Hepatitis B in Resource-Limited Settings
 

Leathers JS1, Pisano MB2, Re V2, Van Oord G3, Sultan A4, Boonstra A3, Debes JD3,5. Ann Glob Health. 2019 Jul 4;85(1). pii: 98. doi: 10.5334/aogh.2562.
 
351.Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers
 

Chang KC1, Chang MH1, Lee CN1, Chang CH1, Wu JF1, Ni YH1, Wen WH2, Shyu MK1, Lai MW3, Chen SM1, Hu JJ1, Lin HH2, Hsu JJ1, Mu SC1, Lin YC2, Liu CJ1, Chen DS1, Lin LH1, Chen HL1; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study). Aliment Pharmacol Ther. 2019 Aug;50(3):306-316. doi: 10.1111/apt.15321. Epub 2019 Jul 4.
 
352.Challenges with hepatitis B vaccination of high risk adults - A pilot program
 

Bridges CB1, Watson TL2, Nelson NP3, Chavez-Torres M4, Fineis P5, Ntiri-Reid B6, Wake E7, Leahy JM8, Kurian AK9, Hall MAK10, Kennedy ED11. Vaccine. 2019 Jul 11. pii: S0264-410X(19)30746-7. doi: 10.1016/j.vaccine.2019.05.089. [Epub ahead of print]
 
353.Hepatitis B testing practices at a tertiary care centre and their associated costs: A retrospective analysis
 

Lawandi A1, Cheng MP1, Lee TC1,2. PLoS One. 2019 Jul 8;14(7):e0219347. doi: 10.1371/journal.pone.0219347. eCollection 2019.
 
354.Hepatitis B and C virus infection and risk of hematological malignancies
 

Marrone A1, Ciotti M2, Rinaldi L1, Adinolfi LE1, Ghany M3. J Viral Hepat. 2019 Jul 20. doi: 10.1111/jvh.13183. [Epub ahead of print]
 
355.Non-invasive biomarkers for chronic hepatitis B virus infection management
 

Charre C1, Levrero M2, Zoulim F2, Scholtès C3. Antiviral Res. 2019 Jul 6;169:104553. doi: 10.1016/j.antiviral.2019.104553. [Epub ahead of print]
 
356.The Effects of Hepatic Steatosis on the Natural History of HBV Infection
 

Suliman I1, Abdelgelil N2, Kassamali F3, Hassanein TI4. Clin Liver Dis. 2019 Aug;23(3):433-450. doi: 10.1016/j.cld.2019.05.001.
 
357.Drugs in the Pipeline for HBV
 

Lopatin U1. Clin Liver Dis. 2019 Aug;23(3):535-555. doi: 10.1016/j.cld.2019.04.006. Epub 2019 May 29.
 
358.Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents
 

Sasadeusz J1, Grigg A2, Hughes PD3, Lee Lim S4, Lucas M5, McColl G6, McLachlan SA7, Peters MG8, Shackel N9, Slavin M10, Sundararajan V11, Thompson A12, Doyle J13, Rickard J2, De Cruz P14, Gish RG15, Visvanathan K12. Clin Liver Dis. 2019 Aug;23(3):521-534. doi: 10.1016/j.cld.2019.04.012. Epub 2019 Jun 5.
 
359.HBV/HDV Coinfection: A Challenge for Therapeutics
 

Koh C1, Da BL2, Glenn JS3. Clin Liver Dis. 2019 Aug;23(3):557-572. doi: 10.1016/j.cld.2019.04.005. Epub 2019 May 24.
 
360.Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations
 

Piaserico S1, Messina F2, Russo FP3. Am J Clin Dermatol. 2019 Jun 20. doi: 10.1007/s40257-019-00457-3. [Epub ahead of print]
 
361.Hepatitis B in Pregnant Women and their Infants
 

Cryer AM1, Imperial JC2. Clin Liver Dis. 2019 Aug;23(3):451-462. doi: 10.1016/j.cld.2019.04.007. Epub 2019 Jun 4.
 
362.Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver Disease
 

Wyles DL1. Clin Liver Dis. 2019 Aug;23(3):473-486. doi: 10.1016/j.cld.2019.04.004. Epub 2019 May 24.
 
363.HBV/HCV Coinfection in the Era of HCV-DAAs
 

Abdelaal R1, Yanny B2, El Kabany M3. Clin Liver Dis. 2019 Aug;23(3):463-472. doi: 10.1016/j.cld.2019.04.003. Epub 2019 May 27.
 
364.Global Perspective on Hepatitis B Virus Infections in the Era of Effective Vaccines
 

Gomes C1, Wong RJ2, Gish RG3. Clin Liver Dis. 2019 Aug;23(3):383-399. doi: 10.1016/j.cld.2019.04.001. Epub 2019 May 23.
 
365.Will Infant Hepatitis B Immunization Protect Adults?
 

Scheifele DW1. Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S64-S66. doi: 10.1097/INF.0000000000002326.
 
366.Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults
 

Sterling RK1, King WC2, Wahed AS2, Kleiner DE3, Khalili M4, Sulkowski M5, Chung RT6, Jain MK7, Lisker-Melman M8, Wong DK9, Ghany MG3; HIV-HBV Cohort Study of the Hepatitis B Research Network. Hepatology. 2019 Jun 20. doi: 10.1002/hep.30825. [Epub ahead of print]
 
367.Exploration of long-acting implant formulations of hepatitis B drug entecavir
 

Henry SJ1, Barrett SE2, Forster SP1, Teller RS1, Yang Z1, Li L1, Mackey MA1, Doto GJ3, Ruth MP3, Tsuchiya T3, Klein LJ1, Gindy ME1. Eur J Pharm Sci. 2019 Jun 15;136:104958. doi: 10.1016/j.ejps.2019.104958. [Epub ahead of print]
 
368.Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015
 

Roberts H1, Boktor SW2, Waller K2, Daar ZS3, Boscarino JA3, Dubin PH1,4, Suryaprasad A1,5, Moorman AC1. PLoS One. 2019 Jun 6;14(6):e0217455. doi: 10.1371/journal.pone.0217455. eCollection 2019.
 
369.Patient-Reported Outcomes in Patients Chronic Viral Hepatitis without Cirrhosis: The Impact of Hepatitis B and C Viral Replication
 

Younossi ZM1,2, Stepanova M3, Younossi I3, Papatheodoridis G4, Janssen HLA5, Agarwal K6, Nguyen MH7, Gane E8, Tsai N9, Nader F3. Liver Int. 2019 Jun 7. doi: 10.1111/liv.14171. [Epub ahead of print]
 
370.Management of Fulminant Hepatitis B
 

Ichai P1,2,3, Samuel D4,5,6. Curr Infect Dis Rep. 2019 Jun 4;21(7):25. doi: 10.1007/s11908-019-0682-9.
 
371.Hepatorenal Syndrome or Hepatocardiorenal Syndrome: Revisiting Basic Concepts in View of Emerging Data
 

Kazory A1, Ronco C2,3. Cardiorenal Med. 2019;9(1):1-7. doi: 10.1159/000492791. Epub 2018 Sep 17.
 
372.Associations Between Hepatitis B Virus Infection and Risk of All Cancer Types
 

Song C1, Lv J2, Liu Y3, Chen JG4, Ge Z1, Zhu J4, Dai J1, Du LB5, Yu C2, Guo Y6, Bian Z6, Yang L6,7, Chen Y6,7, Chen Z6,7, Liu J8, Jiang J9, Zhu L9, Zhai X9, Jiang Y1, Ma H1, Jin G1, Shen H1, Li L2, Hu Z1; China Kadoorie Biobank Collaborative Group. JAMA Netw Open. 2019 Jun 5;2(6):e195718. doi: 10.1001/jamanetworkopen.2019.5718.
 
373.Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis Bvirus infection
 

Marcellin P1, Wong D2, Sievert W3, Buggisch P4, Petersen J4, Flisiak R5, Manns M6,7, Kaita K8, Krastev Z9, Lee SS10, Cathcart AL11, Crans G11, Op den Brouw M12, Jump B11, Gaggar A11, Flaherty J11, Buti-Ferret M13. Liver Int. 2019 May 28. doi: 10.1111/liv.14155. [Epub ahead of print]
 
374.High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation
 

Choi GH1, Kim GA2, Choi J3, Han S4, Lim YS3. Aliment Pharmacol Ther. 2019 May 28. doi: 10.1111/apt.15311. [Epub ahead of print]
 
375.Metabolic Syndrome and Liver Steatosis occur at lower body mass index in US Asian patients with Chronic Hepatitis B
 

Clarke WT1, Miranda J1, Neidich E1, Hudock R1, Peters MG1, Kelly EM2. J Viral Hepat. 2019 May 28. doi: 10.1111/jvh.13147. [Epub ahead of print]
 
376.Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients
 

Lo Re V 3rd1, Newcomb CW1, Carbonari DM1, Roy JA1, Althoff KN2, Kitahata MM3, Reddy KR1, Lim JK4, Silverberg MJ5, Mayor AM6, Horberg MA7, Cachay ER8, Kirk GD2, Hull M9, Gill J10, Sterling TR11, Kostman JR12, Peters MG13, Moore RD2, Klein MB14, Kim HN3; North American AIDS Cohort Collaboration on Research and Design of IeDEA. J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002094. [Epub ahead of print]
 
377.Updates on Chronic HBV: Current Challenges and Future Goals
 

Lee HM1, Banini BA2. Curr Treat Options Gastroenterol. 2019 May 10. doi: 10.1007/s11938-019-00236-3. [Epub ahead of print]
 
378.Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells
 

Dias J1, Hengst J2, Parrot T1, Leeansyah E3, Lunemann S4, Malone DFG1, Hardtke S5, Strauss O1, Zimmer CL1, Berglin L1, Schirdewahn T5, Ciesek S6, Marquardt N1, von Hahn T5, Manns MP5, Cornberg M5, Ljunggren HG1, Wedemeyer H7, Sandberg JK1, Björkström NK8. J Hepatol. 2019 May 6. pii: S0168-8278(19)30270-3. doi: 10.1016/j.jhep.2019.04.009. [Epub ahead of print]
 
379.Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers
 

O'Neil CR1, Congly SE2, Rose MS3, Lee SS2, Borman MA2, Charlton CL4, Osiowy C5, Swain MG2, Burak KW2, Coffin CS6. Ann Hepatol. 2018 Mar - Apr;17(2):232-241. doi: 10.5604/01.3001.0010.8640.
 
380.Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study
 

Bzowej NH1, Tran TT2, Li R3, Belle SH4, Smith CI5, Khalili M6, Chung R7, Tsai N8, Terrault N9; Hepatitis B Research Network (HBRN). Am J Gastroenterol. 2019 May 1. doi: 10.14309/ajg.0000000000000221. [Epub ahead of print]
 
381.Management Approaches to Hepatitis B Virus Vaccination Nonresponse
 

Yanny B1,2, Konyn P1,2, Najarian LM1,2, Mitry A1,2, Saab S1,2. Gastroenterol Hepatol (N Y). 2019 Feb;15(2):93-99.
 
382.Treatment of Viral Infections During Pregnancy
 

Rogan SC1, Beigi RH2. Clin Perinatol. 2019 Jun;46(2):235-256. doi: 10.1016/j.clp.2019.02.009. Epub 2019 Mar 28.
 
383.Hepatitis B Virus and HIV Coinfection: Fibrosis, Fat, and Future Directions
 

Kim AY1. Am J Gastroenterol. 2019 Apr 12. doi: 10.14309/ajg.0000000000000231. [Epub ahead of print]
 
384.A global scientific strategy to cure hepatitis B
 

Revill PA1, Chisari FV2, Block JM3, Dandri M4, Gehring AJ5, Guo H6, Hu J7, Kramvis A8, Lampertico P9, Janssen HLA10, Levrero M11, Li W12, Liang TJ13, Lim SG14, Lu F15, Penicaud MC16, Tavis JE17, Thimme R18; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors, Zoulim F19. Lancet Gastroenterol Hepatol. 2019 Apr 10. pii: S2468-1253(19)30119-0. doi: 10.1016/S2468-1253(19)30119-0. [Epub ahead of print]
 
385.Countdown to 2030: eliminating hepatitis B disease, China
 

Liu J1, Liang W2, Jing W1, Liu M1. Bull World Health Organ. 2019 Mar 1;97(3):230-238. doi: 10.2471/BLT.18.219469. Epub 2019 Jan 28.
 
386.Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection
 

Post G1,2, Shalev N3, Baumgarten A2, Shimakawa Y4, Lemoine M5, Krznaric I2, Dupke S2, Carganico A2, Arastéh K6, Ingiliz P2. Eur J Gastroenterol Hepatol. 2019 Apr 5. doi: 10.1097/MEG.0000000000001409. [Epub ahead of print]
 
387.Evidence for Use of Tenofovir in Pregnancy to Prevent Perinatal Transmission of Hepatitis B Infection
 

Sylvester-Armstrong KR1, Duff WP. Clin Obstet Gynecol. 2019 Mar 27. doi: 10.1097/GRF.0000000000000438. [Epub ahead of print]
 
388.Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus
 

Salvadori N1,2, Fan B3, Teeyasoontranon W4, Ngo-Giang-Huong N1,2,5, Phanomcheong S6, Luvira A7, Puangsombat A8, Suwannarat A9, Srirompotong U10, Putiyanun C11, Cressey TR1,2,5,12, Decker L1,2, Khamduang W2, Harrison L13, Tierney C13, Shepherd JA3,14, Kourtis AP15, Bulterys M15,16, Siberry GK17, Jourdain G1,2,5. Clin Infect Dis. 2019 Mar 29. pii: ciy982. doi: 10.1093/cid/ciy982. [Epub ahead of print]
 
389.Immunetolerant Hepatitis B: Maybe a misnomer but still hard to treat
 

Martin P1. Hepatology. 2019 Apr 9. doi: 10.1002/hep.30654. [Epub ahead of print]
 
390.Sociodemographic, clinical and birth hospitalization characteristics and infant Hepatitis B vaccination in Washington State
 

Oster NV1, Williams EC2, Unger JM3, Newcomb PA4, Jacobson EN5, deHart MP6, Englund JA7, Hofstetter AM7. Vaccine. 2019 Mar 28. pii: S0264-410X(19)30384-6. doi: 10.1016/j.vaccine.2019.03.050. [Epub ahead of print]
 
391.Age, race and viral genotype are associated with the prevalence of Hepatitis B e antigen in children and adults with chronic Hepatitis B
 

Di Bisceglie AM1, King WC2, Lisker-Melman M3, Khalili M4, Belle SH2, Feld JJ5, Ghany MG6, Janssen HLA5, Lau D7, Lee WM8, Ling SC5, Cooper S9, Rosenthal P4, Schwarz KB10, Sterling RK11, Teckman JH1, Terrault N4; Hepatitis B Research Network (HBRN). J Viral Hepat. 2019 Apr 11. doi: 10.1111/jvh.13104. [Epub ahead of print]

Collaborators (37)
 
392.Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients
 

Harris AM1, Millman AJ2, Lora M3, Osinubi A4, Lom J5, Miller LS6. Vaccine. 2019 Apr 10;37(16):2188-2193. doi: 10.1016/j.vaccine.2019.03.012. Epub 2019 Mar 19.
 
393.Screening of Donor and Candidate Prior to Solid Organ Transplantation - Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
 

Malinis M1, Boucher HW2; AST Infectious Diseases Community of Practice. Clin Transplant. 2019 Mar 21:e13548. doi: 10.1111/ctr.13548. [Epub ahead of print]
 
394.Recent advances in the development of HBV capsid assembly modulators
 

Nijampatnam B1, Liotta DC2. Curr Opin Chem Biol. 2019 Apr 2;50:73-79. doi: 10.1016/j.cbpa.2019.02.009. [Epub ahead of print]
 
395.Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients
 

Harris AM1, Millman AJ2, Lora M3, Osinubi A4, Lom J5, Miller LS6. Vaccine. 2019 Apr 10;37(16):2188-2193. doi: 10.1016/j.vaccine.2019.03.012. Epub 2019 Mar 19.
 
396.Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
 

Lee TY1,2, Hsu YC3,4,5,6, Tseng HC7, Yu SH1, Lin JT4,8, Wu MS9, Wu CY7,10,11,12. JAMA Intern Med. 2019 Mar 18. doi: 10.1001/jamainternmed.2018.8342. [Epub ahead of print]
 
397.Sexual Behaviors and Health Practices Among Student Service Members and Veterans
 

Albright DL1, Landor AA2, McDaniel JT3, Godfrey K4, Fletcher KL5, Thomas KH6, Bertram J4. Arch Sex Behav. 2019 Mar 11. doi: 10.1007/s10508-018-1331-3. [Epub ahead of print]
 
398.Pathophysiology and Treatment of Hepatitis B and C Infections in Patients With End-Stage Renal Disease
 

Soi V1, Daifi C2, Yee J2, Adams E2. Adv Chronic Kidney Dis. 2019 Jan;26(1):41-50. doi: 10.1053/j.ackd.2018.10.004.
 
399.Current state-of-the-art pharmacotherapy for the management of hepatitis B infection
 

Tillmann HL1,2, Samuel G1. Expert Opin Pharmacother. 2019 Mar 11:1-13. doi: 10.1080/14656566.2019.1583744. [Epub ahead of print]
 
400.Maintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in patients with chronic hepatitis B
 

Hsu CW1,2, Yeh C3, Yeh CT1,2. J Med Virol. 2019 Feb 28. doi: 10.1002/jmv.25443. [Epub ahead of print]
 
401.Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation
 

Ikeda A1, Takaki A, Yasunaka T, Oyama A, Adachi T, Wada N, Onishi H, Ikeda F, Shiraha H, Yoshida K, Kuise T, Nobuoka D, Yoshida R, Umeda Y, Yagi T, Fujiwara T, Okada H. Acta Med Okayama. 2019 Feb;73(1):41-50. doi: 10.18926/AMO/56457.
 
402.The necessity of education and hepatitis B vaccination for young people: A study of high risk behaviour for blood borne viruses in the United Kingdom
 

Sira J1, Brown M1, Ambegaokar S2, Modin L1, Kelly DA1. J Child Health Care. 2019 Feb 28:1367493519831499. doi: 10.1177/1367493519831499. [Epub ahead of print]
 
403.Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials
 

Buti M1, Wong DK2, Gane E3, Flisiak R4, Manns M5, Kaita K6, Janssen HLA2, Op den Brouw M7, Jump B8, Kitrinos K8, Crans G8, Flaherty J8, Gaggar A8, Marcellin P9. Lancet Gastroenterol Hepatol. 2019 Apr;4(4):296-304. doi: 10.1016/S2468-1253(19)30015-9. Epub 2019 Feb 20.
 
404.The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
 

Popping S1, Bade D2, Boucher C1,2, van der Valk M3, El-Sayed M4, Sigurour O5, Sypsa V6, Morgan T7, Gamkrelidze A8, Mukabatsinda C9, Deuffic-Burban S10, Ninburg M11, Feld J12, Hellard M13, Ward J14,15. J Virus Erad. 2019 Jan 1;5(1):60-66.
 
405.Achieving Excellence in Hepatitis B Virus Care for Veterans in the Veterans Health Administration
 

Chartier M1, Maier MM1, Morgan TR1, Lowy E1, Hoffman-Högg L1, Ross D1, Beste LA1. Fed Pract. 2018 Mar;35(Suppl 2):S49-S53.
 
406.Hepatitis B: Screening, Prevention, Diagnosis, and Treatment
 

Wilkins T1, Sams R1, Carpenter M1.Author informationAm Fam Physician. 2019 Mar 1;99(5):314-323.
 
407.Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017
 

Woodring J, Pastore R, Brink A, Ishikawa N, Takashima Y, Tohme RA. MMWR Morb Mortal Wkly Rep. 2019 Mar 1;68(8):195-200. doi: 10.15585/mmwr.mm6808a2.
 
408.Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B
 

Wei MT1, Le AK1, Chang MS2, Hsu H3, Nguyen P1, Zhang JQ4, Wong C5, Wong C6, Cheung R7, Nguyen MH1. J Med Virol. 2019 Feb 18. doi: 10.1002/jmv.25433. [Epub ahead of print]
 
409.A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators?
  Leung J1, Peacock A1, Colledge S2, Grebely J3, Cunningham EB3, Hickman M4, Vickerman P4, Stone J4, Trickey A4, Dumchev K5, Lynskey M6, Hines L4, Griffiths P7, Mattick RP1, Degenhardt L1, Larney S1. J Infect Dis. 2019 Feb 6. doi: 10.1093/infdis/jiz058. [Epub ahead of print]
 
410.Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses
  Zhou K1, Contag C2, Whitaker E3, Terrault N4. Lancet Gastroenterol Hepatol. 2019 Jan 21. pii: S2468-1253(18)30308-X. doi: 10.1016/S2468-1253(18)30308-X. [Epub ahead of print]
 
411.Bridging the access gap: Medicare ineligibility in people living with chronic hepatitis B
  MacLachlan JH1,2, Cowie BC1,2,3. Intern Med J. 2019 Jan;49(1):122-125. doi: 10.1111/imj.14175.
 
412.Primary Care for Persons Who Inject Drugs
  Visconti AJ1, Sell J2, Greenblatt AD3. Am Fam Physician. 2019 Jan 15;99(2):109-116.
 
413.Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017
  Abara WE, Collier MG, Moorman A, Bixler D, Jones J, Annambhotla P, Bowman J, Levi ME, Brooks JT, Basavaraju SV. MMWR Morb Mortal Wkly Rep. 2019 Jan 25;68(3):61-66. doi: 10.15585/mmwr.mm6803a2.
 
414.Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices
  Ramsey SD1, Unger JM2,3, Baker LH4, Little RF5, Loomba R6, Hwang JP7, Chugh R4, Konerman MA4, Arnold K2,3, Menter AR8, Thomas E9, Michels RM10, Jorgensen CW10, Burton GV11, Bhadkamkar NA7, Hershman DL12. JAMA Oncol. 2019 Jan 17. doi: 10.1001/jamaoncol.2018.6437. [Epub ahead of print]
 
415.Hepatitis B Virus Infection: What Is Current and New
  Peters MG1. Top Antivir Med. 2019 Jan;26(4):112-116.
 
416.Hepatitis B Treatment: What We Know Now and What Remains to Be Researched
  Suk-Fong Lok A1. Hepatol Commun. 2018 Nov 15;3(1):8-19. doi: 10.1002/hep4.1281. eCollection 2019 Jan.
 
417.Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir
  Kong Y1, Sun Y1, Zhou J1, Wu X1, Chen Y2, Piao H3, Lu L4, Ding H5, Nan Y6, Jiang W7, Xu Y8, Xie W9, Li H10, Feng B11, Shi G12, Chen G13, Li H14, Zheng H15, Cheng J16, Wang T17, Liu H18, Fudong L18, Chen S17, Mao Y19, Sun J20, Chen T21, Han T22, Han Y23, Wang L1, Ou X1, Zhang H24, Jia J1, You H1. J Viral Hepat. 2019 Jan 9. doi: 10.1111/jvh.13058. [Epub ahead of print]
 
418.Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016
  Patel EU1, Thio CL2, Boon D3, Thomas DL2, Tobian AAR1. Clin Infect Dis. 2019 Jan 3. doi: 10.1093/cid/ciz001. [Epub ahead of print]
 
419.Discovery of half-life of circulating HBsAg in patients with chronic hepatitis B infection using heavy water labeling
  Loomba R1, Decaris M2, Li KW2,3, Shankaran M3, Mohammed H2,3, Matthews M2,3, Richards LM1, Nguyen P1, Rizo E1, Andrews B1, Soto R1, Angel T3, Suri V4, Kitrinos KM4, Barnes D4, Czerwieniec G4, Brendza K4, Subramanian GM4, Gaggar A4, Hellerstein MK2,3. Clin Infect Dis. 2018 Dec 24. doi: 10.1093/cid/ciy1100. [Epub ahead of print]
 
420.New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection
  Coffin CS1, Zhou K2, Terrault NA3. Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35285-5. doi: 10.1053/j.gastro.2018.11.037. [Epub ahead of print]
 
421.The push is on to cure hepatitis B, a long-overlooked scourge of millions
  Jon Cohen
 
422.Defining the therapeutic range for adalimumab and predicting response in psoriasis: a multicenter prospective observational cohort study
  Wilkinson N1, Tsakok T2, Dand N2, Bloem K3, Duckworth M4, Baudry D4, Pushpa-Rajah A4, Griffiths CE5, Reynolds N6, Barker J2, Warren RB5, Burden AD7, Rispens T3, Stocken D8, Smith C9; BSTOP study group and PSORT consortium. J Invest Dermatol. 2018 Aug 18. pii: S0022-202X(18)32482-5. doi: 10.1016/j.jid.2018.07.028. [Epub ahead of print]
 
423.Ustekinumab use in patients with severe psoriasis co-infected with hepatitis B and/or C
  Siegel S1, Winthrop K2, Ehst B3, Ortega Loayza A4. Br J Dermatol. 2018 Nov 20. doi: 10.1111/bjd.17444. [Epub ahead of print]
 
424.Prevalent misconceptions about opioid use disorders in the United States produce failed policy and public health responses
  Heimer R1,2, Hawk K3, Vermund SH1,4. Clin Infect Dis. 2018 Nov 17. doi: 10.1093/cid/ciy977. [Epub ahead of print]
 
425.Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis
  Song J1, Yang F1, Wang S1, Tikande S1, Deng Y1, Tang W1, Cao G1. J Viral Hepat. 2018 Nov 11. doi: 10.1111/jvh.13036. [Epub ahead of print]
 
426.Assessing the Impact of Electronic Health Record Interventions on Hepatitis B Screening and Vaccination
  Weir RC, Toyoji M, McKee M, Li V, Wang CC. J Health Care Poor Underserved. 2018;29(4):1587-1605. doi: 10.1353/hpu.2018.0114.
 
427.Acute Hepatitis B with Pancreatitis and Cholecystitis Leading to Acute Liver Failure and Death
  Albert AR1, Valencia R2, Smereck JA2. Clin Pract Cases Emerg Med. 2018 Aug 15;2(4):304-308. doi: 10.5811/cpcem.2018.7.38344. eCollection 2018 Nov.
 
428.Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues
  Chevaliez S1,2, Rodriguez C1,2, Poiteau L1,2, Soulier A1,2, Donati F1,2, Darty-Mercier M1,2, Pioche C3, Leroy V4,5, Brodard V6, Zoulim F7,8, Brouard C3, Larsen C3, Semaille C3, Roudot-Thoraval F9, Pawlotsky JM1,2; Hepatology Reference Centers Laboratories Network for Chronic Hepatitis BSurveillance. J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13025. [Epub ahead of print]
 
429.Combination of entecavir/ peginterferon alfa-2a in children with HBeAg-positive immune tolerant chronic hepatitis B virus infection
  Rosenthal P1, Ling SC2, Belle SH3, Murray KF4, Rodriguez-Baez N5, Schwarzenberg SJ6, Teckman J7, Lin HS3, Schwarz KB8; Hepatitis B Research Network (HBRN). Hepatology. 2018 Oct 15. doi: 10.1002/hep.30312. [Epub ahead of print]
 
430.Serum HBV RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection
  Liu S1, Zhou B1,2, Valdes JD2, Sun J1, Guo H2. Hepatology. 2018 Oct 25. doi: 10.1002/hep.30325. [Epub ahead of print]
 
431.Management of chronic hepatitis B during pregnancy
  Aslam A1, Campoverde Reyes KJ1,2, Malladi VR1, Ishtiaq R1, Lau DTY1. Gastroenterol Rep (Oxf). 2018 Nov;6(4):257-262. doi: 10.1093/gastro/goy025. Epub 2018 Jul 24.
 
432.Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
  Klein NP1, Abu-Elyazeed R2, Cheuvart B3, Janssens W3, Mesaros N3. Hum Vaccin Immunother. 2018 Nov 16. doi: 10.1080/21645515.2018.1549449. [Epub ahead of print]
 
433.What is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats
  Ward JW1, Hinman AR2. Gastroenterology. 2018 Nov 1. pii: S0016-5085(18)35205-3. doi: 10.1053/j.gastro.2018.10.048. [Epub ahead of print]
 
434.Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
  Bakacs T1, Safadi R2, Kovesdi I3. Hepatol Med Policy. 2018 Jan 5;3:2. doi: 10.1186/s41124-017-0028-x. eCollection 2018.
 
435.Lichen striatus-like eruption in an adult following hepatitis B vaccination: a case report and review of the literature
  Jones J1, Marquart JD, Logemann NF, DiBlasi DR. Dermatol Online J. 2018 Jul 15;24(7). pii: 13030/qt1hr764kv.
 
436.The impact of currently licensed therapies on viral and immune responses in Chronic Hepatitis B: considerations for future novel therapeutics
  Gill US1,2, Kennedy PTF1,2. J Viral Hepat. 2018 Nov 11. doi: 10.1111/jvh.13040. [Epub ahead of print]
 
437.A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease
  da Silva EN1,2,3, Baker A4, Alshekaili J1,2, Karpe K5, Cook MC1,2,3. PLoS One. 2018 Oct 10;13(10):e0204477. doi: 10.1371/journal.pone.0204477. eCollection 2018.
 
438.Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California
  Toy M1, Wei B1, Virdi TS1, Le A2, Trinh H3, Li J4, Zhang J5, Hsing AW6, So SK1, Nguyen MH2. Hepatol Med Policy. 2018 Jun 5;3:6. doi: 10.1186/s41124-018-0034-7. eCollection 2018.
 
439.Hepatitis B Prevalence and Risk Factors in a Foreign-Born Asian and Pacific Islander Population at a Community Health Center in Hawai'i
  Ferrer A1, Katz AR1, Hurwitz EL1, Pham T2. Asia Pac J Public Health. 2018 Sep 22:1010539518800359. doi: 10.1177/1010539518800359. [Epub ahead of print]
 
440.Risk factors for liver disease among adults of Mexican descent in the United States and Mexico
  Flores YN1, Zhang ZF2, Bastani R3, Leng M4, Crespi CM5, Ramírez-Palacios P1, Stevens H6, Salmerón J1. World J Gastroenterol. 2018 Oct 7;24(37):4281-4290. doi: 10.3748/wjg.v24.i37.4281.
 
441.B in IT - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool
  O'Leary DA1, Cropp E1, Isaac D2,3, Desmond PV1, Bell S1, Nguyen T1, Wong D1, Howell J1, Richmond J4,5,6, O'Neill J7, Thompson AJ1. Hepatol Med Policy. 2018 Jan 4;3:1. doi: 10.1186/s41124-017-0031-2. eCollection 2018.
 
442.Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
  Chen HY#1, Shen DT#1, Ji DZ#2, Han PC1, Zhang WM2, Ma JF1, Chen WS3, Goyal H4, Pan S1, Xu HG1. Gut. 2018 Sep 18. pii: gutjnl-2018-316601. doi: 10.1136/gutjnl-2018-316601. [Epub ahead of print]
 
443.Declining in liver stiffness can not indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study
  Dong XQ1, Wu Z1, Li J1,2, Wang GQ1,3,2, Zhao H1,2; China HepB-Related Fibrosis Assessment Research Group. J Gastroenterol Hepatol. 2018 Oct 5. doi: 10.1111/jgh.14498. [Epub ahead of print]
 
444.Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis
  Ford N1, Scourse R2, Lemoine M3, Hutin Y1, Bulterys M1, Shubber Z4, Donchuk D5, Wandeler G6. Hepatol Commun. 2018 Sep 25;2(10):1160-1167. doi: 10.1002/hep4.1247. eCollection 2018 Oct.
 
445.Healthcare Resource Utilization and Costs by Disease Severity in an Insured National Sample of US Patients with Chronic Hepatitis B
  Nguyen MH1, Ozbay AB2, Liou I3, Meyer N4, Gordon SC5, Dusheiko G6, Lim JK7. J Hepatol. 2018 Oct 1. pii: S0168-8278(18)32440-1. doi: 10.1016/j.jhep.2018.09.021. [Epub ahead of print]
 
446.Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood
  McNaughton AL1, D'Arienzo V2, Ansari MA1, Lumley SF3, Littlejohn M4, Revill P4, McKeating JA2, Matthews PC3. Gastroenterology. 2018 Sep 27. pii: S0016-5085(18)35076-5. doi: 10.1053/j.gastro.2018.07.058. [Epub ahead of print]
 
447.Hepatitis B and C
  Mysore KR1, Leung DH2. Clin Liver Dis. 2018 Nov;22(4):703-722. doi: 10.1016/j.cld.2018.06.002. Epub 2018 Aug 22.
 
448.Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis
  Kennedy K1, Graham SM1,2, Arora N3, Shuhart MC4, Kim HN1,2. PLoS One. 2018 Sep 25;13(9):e0204031. doi: 10.1371/journal.pone.0204031. eCollection 2018.
 
449.The prevalence of undetectable vaccine-induced immunity against hepatitis B virus in US adults at high risk for infection
  Yeo YH1, Le MH1, Chang ET2, Henry L1, Nguyen MH1. Hepatology. 2018 Sep 23. doi: 10.1002/hep.30285. [Epub ahead of print]
 
450.Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study
  Groom HC1, Irving SA2, Koppolu P2, Smith N2, Vazquez-Benitez G3, Kharbanda EO3, Daley MF4, Donahue JG5, Getahun D6, Jackson LA7, Tse Kawai A8, Klein NP9, McCarthy NL10, Nordin JD3, Sukumaran L10, Naleway AL2. Vaccine. 2018 Oct 1;36(41):6111-6116. doi: 10.1016/j.vaccine.2018.08.074. Epub 2018 Sep 5.
 
451.Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
  Dodd RY1, Nguyen ML2, Krysztof DE2, Notari EP1, Stramer SL2. Transfusion. 2018 Sep;58(9):2166-2170. doi: 10.1111/trf.14784. Epub 2018 Aug 24.
 
452.Advancing age and comorbidity in a United States insured population-based cohort of patients with chronic hepatitis B
  Nguyen MH1, Lim JK2, Ozbay AB3, Fraysse J3, Liou I4, Meyer N5, Dusheiko G6,7, Gordon SC8. Hepatology. 2018 Sep 2. doi: 10.1002/hep.30246. [Epub ahead of print]
 
453.HBV core variants, liver fibrosis and hepatocellular carcinoma
  Ligat G1,2, Schuster C1,2, Baumert TF1,2,3,4. Hepatology. 2018 Aug 23. doi: 10.1002/hep.30231. [Epub ahead of print]
 
454.Towards the elimination of hepatitis B and hepatocellular carcinoma
  Spearman CW1. S Afr Med J. 2018 Aug 8;108(8b):13-16. doi: 10.7196/SAMJ.2018.v108i8b.13496.
 
455.A Review of the Hepatitis B Foundation Website
  Spratt S1, Stewart M1, Paige SR2, Stellefson M1. Health Promot Pract. 2018 Aug 15:1524839918790938. doi: 10.1177/1524839918790938. [Epub ahead of print]
 
456.Resource Utilization and Outcomes of Medicare Recipients With Chronic Hepatitis B in the United States
  Kim M1, Paik J2, Golabi P1,2, Jeffers T2, Mishra A1, Younossi ZM1,2. J Clin Gastroenterol. 2018 Aug 13. doi: 10.1097/MCG.0000000000001110. [Epub ahead of print]
 
457.Preventing Perinatal Transmission of Hepatitis B Necessitates Consideration of Antiviral Treatment in Pregnancy
  Terrault N1, Brown R Jr2, Lok A3, Wong J4, Chang KM5, Jonas M6, McMahon B7. Hepatology. 2018 Aug 2. doi: 10.1002/hep.30137. [Epub ahead of print]
 
458.The efficacy of Tenofivir to prevent perinatal transmission in chronic hepatitis B mothers'. a clinical perspective
  Mubarak G1, Ferstenberg R2. Hepatology. 2018 Aug 2. doi: 10.1002/hep.30138. [Epub ahead of print]
 
459.Mortality among Patients with Chronic Hepatitis B (CHB) Infection: the Chronic Hepatitis Cohort Study (CHeCS)
  Bixler D1, Zhong Y1, Ly KN1, Moorman AC1, Spradling PR1, Teshale EH1, Rupp L LB2, Gordon SC2, Boscarino JA3, Schmidt MA4, Daida YG5, Holmberg SD1; CHeCS Investigators. Clin Infect Dis. 2018 Jul 28. doi: 10.1093/cid/ciy598. [Epub ahead of print]
 
460.Global HBV burden: guesstimates and facts
  Ginzberg D1,2, Wong RJ3, Gish R1,2. Hepatol Int. 2018 Jul;12(4):315-329. doi: 10.1007/s12072-018-9884-8. Epub 2018 Jul 27.
 
461.Commentary: A review of risk of hepatitis B and C transmission through biting or spitting
  Pintilie H1, Brook G2. J Viral Hepat. 2018 Jul 26. doi: 10.1111/jvh.12976. [Epub ahead of print]
 
462.Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001-2012
  Moore MS1, Bocour A1, Tran OC2, Qiao B3, Schymura MJ3, Laraque F4, Winters A4. Open Forum Infect Dis. 2018 Jun 16;5(7):ofy144. doi: 10.1093/ofid/ofy144. eCollection 2018 Jul.
 
463.Access to Treatment for Hepatitis B Virus Infection - Worldwide, 2016
  Hutin Y, Nasrullah M, Easterbrook P, Nguimfack BD, Burrone E, Averhoff F, Bulterys M. MMWR Morb Mortal Wkly Rep. 2018 Jul 20;67(28):773-777. doi: 10.15585/mmwr.mm6728a2.
 
464.Maternal Hepatitis B Infection and Pregnancy Outcomes in the United States: A Population-Based Cohort Study
  Bajema KL1, Stankiewicz Karita HC1, Tenforde MW1, Hawes SE2, Heffron R2,3. Open Forum Infect Dis. 2018 Jun 9;5(6):ofy134. doi: 10.1093/ofid/ofy134. eCollection 2018 Jun.
 
465.Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
  Schillie S1, Vellozzi C1, Reingold A2, Harris A1, Haber P3, Ward JW1, Nelson NP1. MMWR Recomm Rep. 2018 Jan 12;67(1):1-31. doi: 10.15585/mmwr.rr6701a1.
 
466.Association Between Hepatitis B Infection and Pancreatic Cancer: A Population-Based Analysis in the United States
  Desai R, Patel U1, Sharma S2, Singh S3, Doshi S4, Shaheen S5, Shamim S6, Korlapati LS7, Balan S8, Bray C4, Williams R9, Shah N10. Pancreas. 2018 Aug;47(7):849-855. doi: 10.1097/MPA.0000000000001095.
 
467.Exploring the feasibility of targeted chronic hepatitis B screening in the emergency department: A pilot study
  Brock C1, Yi Y1, Papaluca T2, Lucas B3, Angus PW1,2, Taylor D1,4, Leung C1,2. Emerg Med Australas. 2018 Jun 9. doi: 10.1111/1742-6723.13118. [Epub ahead of print]
 
468.Safety and Efficacy of Vesatolimod (GS-9620) in Patients with Chronic Hepatitis B Who Are Not Currently on Antiviral Treatment
  Agarwal K1, Ahn SH2, Elkhashab M3, Lau AH4, Gaggar A4, Bulusu A4, Tian X4, Cathcart AL4, Woo J4, Subramanian GM4, Andreone P5, Kim HJ6, Chuang WL7, Nguyen MH8. J Viral Hepat. 2018 May 31. doi: 10.1111/jvh.12942. [Epub ahead of print]
 
469.Strategies for the treatment of HBV/HDV
  Krause A1, Haberkorn U1, Mier W1. Eur J Pharmacol. 2018 Jun 20. pii: S0014-2999(18)30360-1. doi: 10.1016/j.ejphar.2018.06.030. [Epub ahead of print]
 
470.Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand
  Maini MK1, Pallett LJ2. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):192-202. doi: 10.1016/S2468-1253(18)30007-4.
 
471.Hepatitis B vaccination and screening among foreign-born women of reproductive age in the United States: 2013-2015
  Kilmer GA1, Barker LK1, Ly KN1, Jiles RB1. Clin Infect Dis. 2018 Jun 1. doi: 10.1093/cid/ciy479. [Epub ahead of print]
 
472.Hepatitis B virus reactivation in patients treated with immunosuppressive drugs: a practical guide for clinicians
  Koffas A1, Dolman GE2, Kennedy PT3. Clin Med (Lond). 2018 Jun;18(3):212-218. doi: 10.7861/clinmedicine.18-3-212.
 
473.Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study
  Stasi C1, Silvestri C1, Berni R2, Brunetto MR3, Zignego AL4, Orsini C2, Milani S5, Ricciardi L6, De Luca A7, Blanc P8, Nencioni C9, Aquilini D10, Bartoloni A11, Bresci G12, Marchi S13, Filipponi F14, Colombatto P3, Forte P5, Galli A5, Luchi S6, Chigiotti S9, Nerli A10, Corti G11, Sacco R12, Carrai P14, Ricchiuti A13, Giusti M15, Almi P16, Cozzi A5, Carloppi S17, Laffi G18, Voller F1, Cipriani F19. World J Hepatol. 2018 May 27;10(5):409-416. doi: 10.4254/wjh.v10.i5.409.
 
474.An ultra-sensitive Abbott ARCHITECT® assay for the detection of hepatitis Bvirus surface antigen (HBsAg)
  Lou S1, Taylor R2, Pearce S3, Kuhns M4, Leary T5. J Clin Virol. 2018 May 21;105:18-25. doi: 10.1016/j.jcv.2018.05.009. [Epub ahead of print]
 
475.Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial
  Yim HJ1, Kim IH2, Suh SJ1, Jung YK1,3, Kim JH4, Seo YS5, Yeon JE4, Kim CW6, Kwon SY7, Park SH8, Lee MS8, Um SH5, Byun KS4. J Viral Hepat. 2018 May 17. doi: 10.1111/jvh.12934. [Epub ahead of print]
 
476.Hepatitis B Virus Testing and Care among Pregnant Women Using Commercial Claims Data, United States, 2011-2014
  Harris AM1, Isenhour C1, Schillie S1, Vellozzi C1. Infect Dis Obstet Gynecol. 2018 Apr 1;2018:4107329. doi: 10.1155/2018/4107329. eCollection 2018.
 
477.Hepatitis D Viremia Among Injection Drug Users in San Francisco
  Mahale P1, Aka PV1,2, Chen X3,4, Liu P3, Fram BJ5, Wang AS1, Simenel S5, Tseng FC1, Chen S6, Edlin BR7,8, Glenn JS3,5, O'Brien TR1. J Infect Dis. 2018 May 25;217(12):1902-1906. doi: 10.1093/infdis/jiy157.
 
478.Examining Hepatitis, A and B Vaccination, and HBV Reactivation Monitoring During Direct-Acting Antiviral Therapy for Hepatitis C
  Davison J1, O'Shea A2,3, Waterbury N4,5, Villalvazo Y2,6. J Community Health. 2018 May 30. doi: 10.1007/s10900-018-0530-0. [Epub ahead of print]
 
479.Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV)
  Blackard JT1, Sherman KE1. Rev Med Virol. 2018 May 15:e1984. doi: 10.1002/rmv.1984. [Epub ahe